generic_name,preferred_name,originator,nsc,cas,target,type,project_code,smiles
Danusertib,PHA-739538,Pfizer,784415,827318-97-8,Aurora,Investigational,DPT-110,
,CPI-0610,Constellation,784856,1380087-89-7,BET,Investigational,DPT-110,
,Bet-BAY-002,Bayer,785345,1588521-78-1,Bromodomain,Investigational,DTP-110,
,RX-3117,Rexahn,785657,865838-26-2,DNA methyltransferase,Investigational,DTP-110,
,EGF-816,Novartis,787027,1508250-71-2,EGFR,Investigational,DTP-110,
,BLU-9931,,785300,,FGFR,Investigational,DTP-110,
,BMS-983970,BMS,785222,1584713-87-0,Gamma Secretase,Investigational,DPT-110,
,INCB-24360,,785497,1204669-58-8,IDO,Investigational,DPT-110,
,GSK-2879552,,783917,,LSD1,Investigational,DPT-110,
Pyridoclax,MR-29072,,783916,1651890-44-6,Mcl-1,Investigational,DPT-110,
,A-1210477,AbbVie,784817,,Mcl-1,Investigational,DPT-110,
,MI-503,Univ of Michigan,787039,,MLL,Investigational,DPT-110,
,BAY-1161909,Bayer,787025,1443763-60-7,MPS1,Investigational,DPT-110,
,BAY-1217389,Bayer,787026,1554458-53-5,MPS1,Investigational,DPT-110,
,AZD-3147,AstraZeneca,784815,1101810-02-9,mTOR,Investigational,DPT-110,
,CB-5083,Cleave,786100,1542705-92-9,p97,Investigational,DTP-110,
,AZD-8835,AstraZeneca,786099,1620576-64-8,PI3K,Investigational,DTP-110,
,PQR-309,Piqur,785117,1225037-39-7,PI3K/mTOR,Investigational,DTP-110,
,EPZ-015666,Epizyme,785299,1616391-65-1,PRMT5,Investigational,DTP-110,
,BAY-1143572,Bayer,786098,1414943-88-6,PTEFb/CDK9,Investigational,DTP-110,
,AZD-9496,AstraZeneca,786959,1639042-08-2,SERD,Investigational,DTP-110,
Aldoxorubicin,INNO-206,BMS,784722,1361644-26-9,Topo II,Investigational,DPT-110,
,LOXO-101,Loxo Oncology,785570,1223403-58-4,Trk,Investigational,DPT-110,
,MLN-7243,Millennium,785004,1450833-55-2,Ubiquitin-Activating E1,Investigational,DPT-110,
Altiratinib,DCC-2701,Deciphera,784590,,VEGFR,Investigational,DTP-110,
,CCT-251545,Cancer Research Tech,784591,,Wnt,Investigational,DTP-110,
Cladribine,RJW-26251,Merck,105014,4291-63-8,Adenosine deaminase,Approved,DTP-103,Nc1nc(Cl)nc2c1ncn2C3CC(O)C(CO)O3
,CPI-613,Cornerstone,766888,95809-78-2,AEMD,Investigational,DTP-110,OC(=O)CCCCC(CCSCc1ccccc1)SCc2ccccc2
Perifosine,KRX-0401,Keryx Biopharmaceuticals,639966,157716-52-4,Akt,Investigational,DTP-110,CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1
,MK-2206,Merck,756656,1032349-77-1,Akt,Investigational,DTP-110,NC1(CCC1)c2ccc(cc2)c3nc4C=CN5C(=O)NN=C5c4cc3c6ccccc6
,CCT-128930,Astex,761387,885499-61-6,Akt,Investigational,DTP-110,NC1(Cc2ccc(Cl)cc2)CCN(CC1)c3ncnc4[nH]ccc34
,AZD-5363,AstraZeneca,764039,1143532-39-1,Akt,Investigational,DTP-110,NC1(CCN(CC1)c2ncnc3[nH]ccc23)C(=O)N[C@@H](CCO)c4ccc(Cl)cc4
,GSK-690693 ,GlaxoSmithKline,766991,937174-76-0,Akt,Investigational,DTP-110,CCn1c(nc2c(ncc(OC[C@H]3CCCNC3)c12)C#CC(C)(C)O)c4nonc4N
,GDC-0068,Roche,767898,1001264-89-6,Akt,Investigational,DTP-110,CC(C)NC[C@@H](C(=O)N1CCN(CC1)c2ncnc3[C@H](O)C[C@@H](C)c23)c4ccc(Cl)cc4
,PF-4176340,Pfizer,768070,1004990-28-6,Akt,Investigational,DTP-110,CCc1c[nH]c2ncnc(N3CC[C@](N)(CNC(=O)c4ccc(F)cc4F)C3)c12
,AT-13148 HCl,Astex,771650,1056901-62-2,Akt,Investigational,DTP-110,NC[C@@](O)(c1ccc(Cl)cc1)c2ccc(cc2)c3cn[nH]c3
Afuresertib,GSK-2110183,GlaxoSmithKline,778305,1047644-62-1,Akt,Investigational,DTP-110,Cn1ncc(Cl)c1c2cc(sc2Cl)C(=O)N[C@H](CN)Cc3cccc(F)c3
,GSK-2141795,GlaxoSmithKline,778368,1047634-65-0,Akt,Investigational,DTP-110,Cn1ncc(Cl)c1c2cc(oc2Cl)C(=O)N[C@H](CN)Cc3ccc(F)c(F)c3
Plicamycin,A-2371; PA-144,Pfizer,24559,18378-89-7,Alcohol Dehydrogenase,Approved,DTP-103,CO[C@@H]([C@@H]1Cc2cc3cc(OC4CC(OC5CC(O)C(O)C(C)O5)C(O)C(C)O4)c(C)c(O)c3c(O)c2C(=O)[C@H]1OC6CC(OC7CC(OC8CC(C)(O)C(O)C(C)O8)C(O)C(C)O7)C(O)C(C)O6)C(=O)[C@@H](O)[C@@H](C)O
Alectinib,CH-5424802,Chugai,764040,1256580-46-7,Alk,Investigational,DTP-110,CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N5CCC(CC5)N6CCOCC6
,TAE-684,Novartis,764041,761439-42-3,Alk,Investigational,DTP-110,COc1cc(ccc1Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)N4CCC(CC4)N5CCN(C)CC5
,CH-5428402 HCl,Chugai,764821,1256589-74-8,Alk,Investigational,DTP-110,CCc1cc2C(=O)c3c([nH]c4cc(ccc34)C#N)C(C)(C)c2cc1N5CCC(CC5)N6CCOCC6
,ASP-3026,Astellas,765865,1097917-15-1,Alk,Investigational,DTP-110,COc1cc(ccc1Nc2ncnc(Nc3ccccc3S(=O)(=O)C(C)C)n2)N4CCC(CC4)N5CCN(C)CC5
Entrectinib,NMS-E628,Nerviano,774769,1108743-60-7,Alk,Investigational,DTP-110,CN1CCN(CC1)c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC6CCOCC6)c2
,LDK-378,Novartis,776422,1032900-25-6,Alk,Investigational,DTP-110,CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3
Ceritinib,LDK-378,Novartis,776422,1032900-25-6,Alk,Approved,DTP-103,CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3
,AZD-3463,AstraZeneca,776787,1356962-20-3,Alk,Investigational,DTP-110,COc1cc(ccc1Nc2ncc(Cl)c(n2)c3c[nH]c4ccccc34)N5CCC(N)CC5
,LDK-378 HCl,Novartis,777193,1380575-43-8,Alk,Investigational,DPT-110,CC(C)Oc1cc(C2CCNCC2)c(C)cc1Nc3ncc(Cl)c(Nc4ccccc4S(=O)(=O)C(C)C)n3
,CEP-28122,Cephalon,779218,1022958-60-6,Alk,Investigational,DPT-110,COc1c2CC[C@H](CCc2ccc1Nc3ncc(Cl)c(N[C@@H]4[C@@H]5CC(C=C5)[C@@H]4C(=O)N)n3)N6CCOCC6
,PF-06463922,Pfizer,780108,1454846-35-5 ,Alk,Investigational,DPT-110,C[C@H]1Oc2cc(cnc2N)c3c(CN(C)C(=O)c4ccc(F)cc14)nn(C)c3C#N
,SOMCL-12-81,,780163,1609203-73-7,Alk,Investigational,DPT-110,CC(C)S(=O)(=O)c1ccccc1Nc2nc(Nc3cccc(NC(=O)CN)c3)ncc2Cl
,CEP-37440,Teva,781148,1391712-60-9,Alk,Investigational,DPT-110,CNC(=O)c1ccccc1Nc2nc(Nc3ccc4C[C@H](CCCc4c3OC)N5CCN(CCO)CC5)ncc2Cl
Busulfan,KRN-246,GlaxoSmithKline,750,55-98-1,Alkylator,Approved,DTP-103,CS(=O)(=O)OCCCCOS(=O)(=O)C
Nitrogen mustard,,Merck,762,55-86-7,Alkylator,Approved,DTP-103,CN(CCCl)CCCl
Chlorambucil,,GlaxoSmithKline,3088,305-03-3,Alkylator,Approved,DTP-103,OC(=O)CCCc1ccc(cc1)N(CCCl)CCCl
Melphalan,CB-3025,GlaxoSmithKline,8806,148-82-3,Alkylator,Approved,DTP-103,N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(=O)O
Triethylenemelamine,,,9706,51-18-3,Alkylator,Approved,DTP-103,C1CN1c2nc(nc(n2)N3CC3)N4CC4
Altretamine,KB-913 ,Sanofi,13875,645-05-6,Alkylator,Approved,DTP-103,CN(C)c1nc(nc(n1)N(C)C)N(C)C
Pipobroman,A-8103,Abbott,25154,54-91-1,Alkylator,Approved,DTP-103,BrCCC(=O)N1CCN(CC1)C(=O)CCBr
Cyclophosphamide,,BMS,26271,50-18-0,Alkylator,Approved,DTP-103,ClCCN(CCCl)P1(=O)NCCCO1
Uracil mustard,,,34462,66-75-1,Alkylator,Approved,DTP-103,ClCCN(CCCl)C1=CNC(=O)NC1=O
Mitotane,CB-313,BMS,38721,53-19-0,Alkylator,Approved,DTP-103,ClC(Cl)C(c1ccc(Cl)cc1)c2ccccc2Cl
Dacarbazine,,Bayer,45388,4342-03-4,Alkylator,Approved,DTP-103,CN(C)N=Nc1[nH]cnc1C(=O)N
Procarbazine,Ro-04-6467/1 ,Chugai,77213,366-70-1,Alkylator,Approved,DTP-103,CNNCc1ccc(cc1)C(=O)NC(C)C
Lomustine,CCNU,BMS,79037,13010-47-4,Alkylator,Approved,DTP-103,ClCCN(N=O)C(=O)NC1CCCCC1
Ifosfamide,MJF-9325; Z-4942,Baxter,109724,3778-73-2,Alkylator,Approved,DTP-103,ClCCNP1(=O)OCCCN1CCCl
Cisplatin,,BMS,119875,15663-27-1,Alkylator,Approved,DTP-103,[R][Pt+2]([R])([ClH-])[ClH-]
Bendamustine,SDX-105,Cephalon,138783,3543-75-7,Alkylator,Approved,DTP-103,Cn1c(CCCC(=O)O)nc2cc(ccc12)N(CCCl)CCCl
Carboplatin,JM-8,BMS,241240,41575-94-4,Alkylator,Approved,DTP-103,N[Pt]1(N)OC(=O)C2(CCC2)C(=O)O1
Temozolomide,CCRG-81045; Sch-52365,EORTC,362856,85622-93-1,Alkylator,Approved,DTP-103,CN1N=Nc2c(ncn2C1=O)C(=O)N
Carmustine,SK-27702; NPC-08,Eisai,409962,154-93-8,Alkylator,Approved,DTP-103,ClCCNC(=O)N(CCCl)N=O
Irofulven,E-7850,Eisai,683863,158440-71-2,Alkylator,Investigational,DTP-110,CC1=C(CO)C2=C(C)C3(CC3)[C@@](C)(O)C(=O)C2=C1
Estramustine,Ro-21-8837,Roche,702294,52205-73-9,Alkylator,Approved,DTP-103,C[C@]12CC[C@H]3[C@@H](CCc4cc(OC(=O)N(CCCl)CCCl)ccc34)[C@@H]1CC[C@@H]2OP(=O)(O)O
,AZD-3514,AstraZeneca,765776,1240299-33-5,Androgen Receptor,Investigational,DTP-110,CC(=O)N1CCN(CCOc2ccc(cc2)C3CCN(CC3)C4=Nn5c(CC4)nnc5C(F)(F)F)CC1
,ARN-509,Aragon Pharma,771649,956104-40-8,Androgen Receptor,Investigational,DTP-110,CNC(=O)c1ccc(cc1F)N2C(=S)N(C(=O)C23CCC3)c4cnc(C#N)c(c4)C(F)(F)F
Tamoxifen,ICI-46474,AstraZeneca,180973,54965-24-1,Antiestrogen,Approved,DTP-103,
Hydroxyurea,,BMS,32065,127-07-1,Antimetabolite,Approved,DTP-103,NC(=O)NO
,2-Fluoroadenosine,,118218,146-78-1,Antimetabolite,Investigational,DTP-110,Nc1nc(F)nc2c1ncn2C3OC(CO)C(O)C3O
Decitabine,E-7373,Eisai Inc,127716,2353-33-5,Antimetabolite,Approved,DTP-103,NC1=NC(=O)N(C=N1)C2CC(O)C(CO)O2
Pentostatin,CI-825; PD-81565,Pfizer,218321,53910-25-1,Antimetabolite,Approved,DTP-103,OCC1OC(CC1O)n2cnc3[C@H](O)CNC=Nc23
Pemetrexed,LY-231514,Eli Lilly,755384,137281-23-3,Antimetabolite,Approved,DTP-103,NC1=NC(=O)c2c(CCc3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)c[nH]c2N1
Valrubicin,AD-32,Anthra,246131,56124-62-0,Antimitotic,Approved,DTP-103,CCCCC(=O)OCC(=O)[C@@]1(O)C[C@H](OC2CC(NC(=O)C(F)(F)F)C(O)C(C)O2)c3c(O)c4C(=O)c5c(OC)cccc5C(=O)c4c(O)c3C1
Indibulin, ZIP-301,ZioPharm,758489,204205-90-3 ,Antimitotic,Investigational,DTP-110,Clc1ccc(Cn2cc(C(=O)C(=O)Nc3ccncc3)c4ccccc24)cc1
Daunorubicin,NDC-0082-4155,Sanofi,82151,23541-50-6,Antineoplastic,Approved,DTP-103,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)C
Bleomycin,,BMS,125066,9041-93-4,Antineoplastic,Approved,DTP-103,
Quercetin,LNS-5662,Limerick BioPharma,756660,117-39-5,Antioxidant,Investigational,DTP-110,OC1=C(Oc2cc(O)cc(O)c2C1=O)c3ccc(O)c(O)c3
Quinacridine,Acrichine,,14229,83-89-6,Antiprotozoal,Investigational,DTP-110,CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc3ccc(OC)cc13
Arsenic Trioxide,,,92859,1327-53-3,Apoptotic,Approved,DTP-103,O1[As]2O[As]3O[As](O[As]1O3)O2
,ICG-001,Institute for Chemical Genomics,756641,780757-88-2,Apoptotic,Investigational,DTP-110,Oc1ccc(C[C@@H]2N3[C@H](CN(Cc4cccc5ccccc45)C2=O)N(CCC3=O)C(=O)NCc6ccccc6)cc1
Omacetaxine mepasuccinate,CGX-635,Teva,758253,26833-87-4,Apoptotic,Approved,DTP-103,COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@H]1[C@H]2c3cc4OCOc4cc3CCN5CCC[C@]25C=C1OC
Enzalutamide,NC-54; MDV-3100,Medivation,755605,915087-33-1,AR antagonist,Approved,DTP-103,CNC(=O)c1ccc(cc1F)N2C(=S)N(C(=O)C2(C)C)c3ccc(C#N)c(c3)C(F)(F)F
Exemestane,FCE-24304,Pfizer,713563,107868-30-4,Aromatase,Approved,DTP-103,C[C@]12CC[C@H]3[C@@H](CC(=C)C4=CC(=O)C=C[C@]34C)[C@@H]1CCC2=O
Anastrozole,ZD-1033,AstraZeneca,719344,120511-73-1,Aromatase,Approved,DTP-103,CC(C)(C#N)c1cc(Cn2cncn2)cc(c1)C(C)(C)C#N
Letrozole,CGS-20267; FEM-345,Novartis,719345,112809-51-5,Aromatase,Approved,DTP-103,N#Cc1ccc(cc1)C(c2ccc(cc2)C#N)n3cncn3
,NU-6027,AstraZeneca,756874,220036-08-8,ATR,Investigational,DTP-110,Nc1nc(N)c(N=O)c(OCC2CCCCC2)n1
,VE-821,Vertex,761070,1232410-49-9,ATR,Investigational,DTP-110,CS(=O)(=O)c1ccc(cc1)c2cnc(N)c(n2)C(=O)Nc3ccccc3
,Vertex ATR inhibitor Cpd 45,Vertex,761693,1286238-55-8,ATR,Investigational,DTP-110,CC(CN(C)C)S(=O)(=O)c1ccc(cc1)c2cnc(N)c(n2)C(=O)Nc3ccccc3
,AZD-6738 diasteromeric mixture,AstraZeneca,777638,1352226-97-1,ATR,Investigational,DTP-110,
,VE-822,Vertex,777718,1232416-25-9,ATR,Investigational,DTP-110,CNCc1ccc(cc1)c2cc(on2)c3nc(cnc3N)c4ccc(cc4)S(=O)(=O)C(C)C
,AZD-6738,AstraZeneca,780249,,ATR,Investigational,DTP-110,C[C@@H]1COCCN1c2cc(nc(n2)c3ccnc4[nH]ccc34)C5(CC5)[S@](=N)(=O)C
,"AZD-6738 ( R,S-isomer)",AstraZeneca,780250,,ATR,Investigational,DTP-110,C[C@@H]1COCCN1c2cc(nc(n2)c3ccnc4[nH]ccc34)C5(CC5)[S@@](=N)(=O)C
Barasertib,AZD-1152,AstraZeneca,757444,957881-03-7,Aurora,Investigational,DTP-110,CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)n[nH]3)ncnc2c1
,ENMD-2076,Entremed,758245,1453868-32-0,Aurora,Investigational,DTP-110,
,SNS-314,Sunesis,758250,1146618-41-8,Aurora,Investigational,DTP-110,Clc1cccc(NC(=O)Nc2ncc(CCNc3ncnc4ccsc34)s2)c1
,ENMD-2076 Precursor,Entremed,759094,934353-75-0,Aurora,Investigational,DTP-110,CN1CCN(CC1)c2cc(Nc3cc(C)[nH]n3)nc(n2)C#Cc4ccccc4
,CYC-116,Cyclacel,759498,693228-63-6,Aurora,Investigational,DTP-110,Cc1nc(N)sc1c2ccnc(Nc3ccc(cc3)N4CCOCC4)n2
,KW-2449,Kyowa Hakko Kirin,759675,1000669-72-6,Aurora,Investigational,DTP-110,O=C(N1CCNCC1)c2ccc(\C=C\c3n[nH]c4ccccc34)cc2
Alisertib,MLN-8237 ,Millennium,759677,1028486-01-2 ,Aurora,Investigational,DTP-110,COc1cccc(F)c1C2=NCc3cnc(Nc4ccc(C(=O)O)c(OC)c4)nc3c5ccc(Cl)cc25
,AT-9283,Astex,760144,896466-04-9,Aurora,Investigational,DTP-110,O=C(NC1CC1)Nc2c[nH]nc2c3nc4cc(CN5CCOCC5)ccc4[nH]3
,AMG-900,Amgen,761069,945595-80-2,Aurora,Investigational,DTP-110,Cc1csc(c1)c2nnc(Nc3ccc(Oc4ncccc4c5ccnc(N)n5)cc3)c6ccccc26
,SCH-1473759,Merck,761691,1094069-99-4,Aurora,Investigational,DTP-110,CCN(Cc1cc(Nc2nc(C)cn3c(cnc23)c4cn[nH]c4)sn1)C(C)(C)CO
,TAK-901,Takeda,762151,934541-31-8,Aurora,Investigational,DTP-110,CCS(=O)(=O)c1cccc(c1)c2cc(C(=O)NC3CCN(C)CC3)c(C)c4[nH]c5ncc(C)cc5c24
, AS-703569 ,EMD Serono,763930,871357-89-0,Aurora,Investigational,DTP-110,CN1CCN(CC1)c2ccc(Nc3ncc(F)c(N[C@@H]4[C@@H]5C[C@@H](C=C5)[C@@H]4C(=O)N)n3)cc2C
Ilorasertib,ABT-348,Abbott,765889,1227939-82-3,Aurora,Investigational,DTP-110,Nc1ncc(c2cnn(CCO)c2)c3scc(c4ccc(NC(=O)Nc5cccc(F)c5)cc4)c13
,MK-5108,Merck,773262,1010085-13-8,Aurora,Investigational,DTP-110,OC(=O)[C@@]1(Cc2cccc(Nc3nccs3)n2)CC[C@@H](CC1)Oc4cccc(Cl)c4F
,GSK-1070916A,GlaxoSmithKline,777445,942918-07-2,Aurora,Investigational,DTP-110,CCn1cc(c2ccnc3[nH]c(cc23)c4cccc(CN(C)C)c4)c(n1)c5ccc(NC(=O)N(C)C)cc5
,R-428,Rigel,765262,1037624-75-1,Axl,Investigational,DTP-110,Nc1nc(Nc2ccc3CCC(CCc3c2)N4CCCC4)nn1c5cc6CCCc7ccccc7c6nn5
,RAF-265,Novartis,754357,927880-90-8,B-Raf,Investigational,DTP-110,Cn1c(Nc2ccc(cc2)C(F)(F)F)nc3cc(Oc4ccnc(c4)c5ncc([nH]5)C(F)(F)F)ccc13
,SB-590885,GlaxoSmithKline,754362,405554-55-4,B-Raf,Investigational,DTP-110,CN(C)CCOc1ccc(cc1)c2nc(c3ccncc3)c([nH]2)c4ccc5\C(=N\O)\CCc5c4
,Targegen B-Raf/PDGFR inhibitor Cpd 6,TargeGen,754364,877874-85-6,B-Raf,Investigational,DTP-110,CSc1nc(N)cc(Oc2ccc(cc2)c3nnc(Nc4cccc(c4)C(F)(F)F)[nH]3)n1
,PLX-4720,Plexxikon,757438,918505-84-7,B-Raf,Investigational,DTP-110,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F
Vemurafenib,PLX-4032,Plexxikon,761431,1029872-54-5,B-Raf,Approved,DTP-103,CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(cc23)c4ccc(Cl)cc4)c1F
 Dabrafenib,GSK-2118436B,GlaxoSmithKline,764134,1195768-06-9,B-Raf,Approved,DTP-103,CC(C)(C)c1nc(c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(s1)c4ccnc(N)n4
,ARQ-680,ArQule,764765,1228237-45-3,B-Raf,Investigational,DTP-110,Cn1ccc(n1)S(=O)(=O)N2CCC[C@@H](C2)Nc3nccc(n3)c4c(nc5occn45)c6cccc(O)c6
,CEP-32496,Ambit,776043,1188910-76-0,B-Raf,Investigational,DPT-110,COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(on4)C(C)(C)C(F)(F)F)c3)c2cc1OC
Encorafenib,LGX-818,Novartis,778304,1269440-17-6,B-Raf,Investigational,DTP-110,COC(=O)N[C@@H](C)CNc1nccc(n1)c2cn(nc2c3cc(Cl)cc(NS(=O)(=O)C)c3F)C(C)C
,TAK-632,Takeda,778809,1228591-30-7,B-Raf,Investigational,DPT-110,Fc1ccc(Oc2ccc3nc(NC(=O)C4CC4)sc3c2C#N)cc1NC(=O)Cc5cccc(c5)C(F)(F)F
,LY-3009120,Eli Lilly,781761,1454682-72-4,B-Raf,Investigational,DTP-110,CNc1ncc2cc(c(C)nc2n1)c3cc(NC(=O)NCCC(C)(C)C)c(F)cc3C
,AZ-628,AstraZeneca,782007,878739-06-1,B-Raf ,Investigational,DPT-110,CN1C=Nc2ccc(Nc3cc(NC(=O)c4cccc(c4)C(C)(C)C#N)ccc3C)cc2C1=O
(R)-(-)-Gossypol,AT-101; BL-193,Ascenta Therapeutics,727859,90141-22-3,Bcl-2,Investigational,DTP-110,
Obatoclax      ,GX15-070,Gemin X,756663,803712-79-0,Bcl-2,Investigational,DTP-110,COC1=CC(=N/C/1=C/c2[nH]c(C)cc2C)c3cc4ccccc4[nH]3
,ABT-737 ,Abbott Laboratories,758873,852808-04-9,Bcl-2,Investigational,DTP-110,
 Navitoclax,ABT-263,Abbott Laboratories,759659,923564-51-6,Bcl-2,Investigational,DTP-110,CC1(C)CCC(=C(CN2CCN(CC2)c3ccc(cc3)C(=O)NS(=O)(=O)c4ccc(N[C@H](CCN5CCOCC5)CSc6ccccc6)c(c4)S(=O)(=O)C(F)(F)F)C1)c7ccc(Cl)cc7
,ABT-199,Abbott Laboratories,766270,1257044-40-8,Bcl-2,Investigational,DTP-110,CC1(C)CCC(=C(C1)c2ccc(Cl)cc2)CN3CCN(CC3)c4ccc(C(=O)NS(=O)(=O)c5ccc(NCC6CCOCC6)c(c5)[N+](=O)[O-])c(Oc7cnc8[nH]ccc8c7)c4
,BAM7,Dana Farber,768536,331244-89-4,Bcl-2,Investigational,DTP-110,CCOc1ccccc1N\N=C\2/C(=NN(C2=O)c3nc(cs3)c4ccccc4)C
Imatinib,STI-571,Novartis,743414,220127-57-1,Bcr-abl,Approved,DTP-103,CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)CC1
Nilotinib,AMN-107,Novartis,747599,641571-10-0,Bcr-abl,Approved,DTP-103,Cc1cn(cn1)c2cc(NC(=O)c3ccc(C)c(Nc4nccc(n4)c5cccnc5)c3)cc(c2)C(F)(F)F
Ponatinib,AP-24534,Ariad,758487,943319-70-8,Bcr-abl,Approved,DTP-103,CN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(c3)C#Cc4cnc5cccnn45)cc2C(F)(F)F)CC1
Dasatinib,BMS-354825 ,BMS,732517,863127-77-9,Bcr-Abl; c-Kit; PDGFR,Approved,DTP-103,Cc1nc(Nc2ncc(s2)C(=O)Nc3c(C)cccc3Cl)cc(n1)N4CCN(CCO)CC4
,PNU-74654,Pfizer,755984,113906-27-7,Beta-catenin,Investigational,DTP-110,Cc1oc(\C=N\NC(=O)c2ccccc2Oc3ccccc3)cc1
Zolendronic acid,,,721517,118072-93-8,Bisphosphonate,Approved,DTP-103,OC(Cn1ccnc1)(P(=O)(O)O)P(=O)(O)O
,(+)-JQ1,Dana Farber,764043,1268524-70-4,Bromodomain,Investigational,DTP-110,Cc1sc2c(C(=N[C@@H](CC(=O)OC(C)(C)C)c3nnc(C)n23)c4ccc(Cl)cc4)c1C
,GSK-1210151A,GlaxoSmithKline,767599,1300031-49-5,Bromodomain,Investigational,DTP-110,COc1cc2c3N([C@H](C)c4ccccn4)C(=O)Nc3cnc2cc1c5c(C)onc5C
,GSK-525762,GlaxoSmithKline,774829,1260907-17-2,Bromodomain,Investigational,DTP-110,CCNC(=O)C[C@@H]1N=C(c2ccc(Cl)cc2)c3cc(OC)ccc3n4c(C)nnc14
,PFI-1,Pfizer,777448,1403764-72-6,Bromodomain,Investigational,DTP-110,COc1ccccc1S(=O)(=O)Nc2ccc3NC(=O)N(C)Cc3c2
,OTX-015,Mitsubishi,778747,202590-98-5,Bromodomain,Investigational,DPT-110,Cc1sc2c(C(=N[C@@H](CC(=O)Nc3ccc(O)cc3)c4nnc(C)n24)c5ccc(Cl)cc5)c1C
,I-Bet-726,GlaxoSmithKline,782763,1300031-52-0,Bromodomain,Investigational,DTP-110,C[C@H]1C[C@@H](Nc2ccc(Cl)cc2)c3cc(ccc3N1C(=O)C)c4ccc(cc4)C(=O)O
Ibrutinib,PCI-32765; CRA-032765,Pharmacyclics,761910,936563-96-1,BTK,Approved,DTP-103,Nc1ncnc2c1c(nn2C3CCCN(C3)C(=O)C=C)c4ccc(Oc5ccccc5)cc4
Spebrutinib,CC-292,Celgene,780020,1202757-89-9,BTK,Investigational,DPT-110,COCCOc1ccc(Nc2ncc(F)c(Nc3cccc(NC(=O)C=C)c3)n2)cc1
,RN-486,Roche,781417,1242156-23-5,BTK,Investigational,DPT-110,CN1CCN(CC1)c2ccc(NC3=CC(=CN(C)C3=O)c4cccc(N5C=Cc6cc(cc(F)c6C5=O)C7CC7)c4CO)nc2
Masitinib,AB-1010,AB Science,755400,790299-79-5,c-Kit,Investigational,DTP-110,CN1CCN(Cc2ccc(cc2)C(=O)Nc3ccc(C)c(Nc4nc(cs4)c5cccnc5)c3)CC1
,OSI-930 ,OSI,766887, 728033-96-3,c-Kit,Investigational,DTP-110,FC(F)(F)Oc1ccc(NC(=O)c2sccc2NCc3ccnc4ccccc34)cc1
Sorafenib,BAY 43-9006; BAY 54-9085,Bayer,747971,284461-73-0,c-Kit; PDGFR; B-Raf; VEGFR,Approved,DTP-103,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)cc2)ccn1
Sunitinib,SU-011248; PNU-290940AD; SU-010398,Pfizer,750690,557795-19-4,c-Kit; PDGFR; VEGFR,Approved,DTP-103,CCN(CC)CCNC(=O)c1c(C)[nH]c(\C=C\2/C(=O)Nc3ccc(F)cc23)c1C
,AMG-458,Amgen,754346,913376-83-7,c-Met,Investigational,DTP-110,COc1ccc2c(Oc3ccc(NC(=O)C4=C(C)N(CC(C)(C)O)N(C4=O)c5ccccc5)nc3)ccnc2c1
Foretinib,XL-880,Exelixis,755775,849217-64-7,c-Met,Investigational,DTP-110,COc1cc2c(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5)cc3F)ccnc2cc1OCCCN6CCOCC6
Crizotinib,PF-02341066, Pfizer,756645,877399-52-5,c-Met,Approved,DTP-103,
Tivantinib,ARQ-197,ArQule,758242,1000873-98-2,c-Met,Investigational,DTP-110,O=C1NC(=O)[C@H]([C@@H]1c2c[nH]c3ccccc23)c4cn5CCCc6cccc4c56
Tepotinib,EMD-1214063,EMD Serono,758244,1100598-32-0,c-Met,Investigational,DTP-110,CN1CCC(COc2cnc(nc2)c3cccc(CN4N=C(C=CC4=O)c5cccc(c5)C#N)c3)CC1
,SGX-523,SGX,758591,1022150-57-7,c-Met,Investigational,DTP-110,Cn1cc(cn1)c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2
,JNJ-38877605,Johnson & Johnson,759095,1072116-03-0,c-Met,Investigational,DTP-110,Cn1cc(cn1)c2ccc3nnc(n3n2)C(F)(F)c4ccc5ncccc5c4
,MK-8033 ,Merck,761692,1196681-38-5,c-Met,Investigational,DTP-110,Cn1cc(cn1)c2cnc3C=Cc4ccc(CS(=O)(=O)NCc5ccccn5)cc4C(=O)c3c2
,PF-04217903,Pfizer,763931,956905-27-4,c-Met,Investigational,DTP-110,OCCn1cc(cn1)c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2
,BMS-777607,BMS,764090,1196681-44-3,c-Met,Investigational,DTP-110,CCOC1=C(C(=O)Nc2ccc(Oc3ccnc(N)c3Cl)c(F)c2)C(=O)N(C=C1)c4ccc(F)cc4
,MK-2461,Merck,764580,917879-39-1,c-Met,Investigational,DTP-110,CN(C[C@@H]1COCCO1)S(=O)(=O)Nc2ccc3C=Cc4ncc(cc4C(=O)c3c2)c5cnn(C)c5
,S-49076,Servier,765672,1266319-57-6,c-Met,Investigational,DTP-110,O=C1OCCN1Cc2ccc3NC(=O)\C(=C/c4cc(CN5CCOCC5)c[nH]4)\c3c2
,PHA-665752,Pfizer,766271,477575-56-7,c-Met,Investigational,DTP-110,Cc1[nH]c(\C=C\2/C(=O)Nc3ccc(cc23)S(=O)(=O)Cc4c(Cl)cccc4Cl)c(C)c1C(=O)N5CCC[C@@H]5CN6CCCC6
,AMG-208,Amgen,766288,1002304-34-8,c-Met,Investigational,DTP-110,COc1ccc2c(OCc3nnc4ccc(nn34)c5ccccc5)ccnc2c1
,EMD-1204831,Merck Serono,767954,1100598-15-9,c-Met,Investigational,DTP-110,Cn1cc(cn1)C2=NN(Cc3cccc(c3)c4ncc(OCCN5CCOCC5)cn4)C(=O)C=C2
,SAR-125844,Sanofi,771652,1116743-46-4,c-Met,Investigational,DTP-110,Fc1ccc(cc1)c2ccc3nnc(Sc4ccc5nc(NC(=O)NCCN6CCOCC6)sc5c4)n3n2
Merestinib,LY-2801653,Eli Lilly,772197,1206799-15-6,c-Met,Investigational,DTP-110,CC1=CC=C(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3c5cn[nH]c5)c(F)c2)C(=O)N1c6ccc(F)cc6
Capmatinib,INCB-28060,Incyte,777878,1029712-80-8,c-Met,Investigational,DTP-110,CNC(=O)c1ccc(cc1F)c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2
Ningetinib,CT-053PTSA,HEC Pharma,781652,1394820-69-9,c-Met,Investigational,DTP-110,CN1N(C(=O)C(=C1C)C(=O)Nc2ccc(Oc3ccnc4cc(OCC(C)(C)O)ccc34)c(F)c2)c5ccccc5
Volitinib,AZD-6094,AstraZeneca,782121,1313725-88-0,c-Met,Investigational,DTP-110,C[C@@H](c1ccc2nccn2c1)n3nnc4ncc(nc34)c5cnn(C)c5
Cabozantinib,XL-184; BMS-907351,Exelixis,761068,1140909-48-3,c-Met; VEGFR2,Approved,DTP-103,COc1cc2nccc(Oc3ccc(NC(=O)C4(CC4)C(=O)Nc5ccc(F)cc5)cc3)c2cc1OC
,10058-F4,Univ Pittsburgh,764582,403811-55-2,c-Myc,Investigational,DTP-110,CCc1ccc(\C=C/2\SC(=S)NC2=O)cc1
,10074-G5,Univ Pittsburgh,764609,413611-93-5,c-Myc,Investigational,DTP-110,[O-][N+](=O)c1ccc(Nc2ccccc2c3ccccc3)c4nonc14
Abiraterone,JNJ-2012082,BTG,749226,154229-18-2,C17-20 Lyase,Approved,DTP-103,C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@]34C)[C@@H]1CC=C2c5cccnc5
Orteronel,TAK-700,Takeda,764488,426219-23-0,C17-20 Lyase,Investigational,DTP-110,CNC(=O)c1ccc2cc(ccc2c1)C3(O)CCn4cncc34
,VT-464,Vertex,783294,1598419-61-4,C17-20 Lyase,Investigational,DTP-110,CC(C)[C@](O)(c1ccc2cc(OC(F)F)c(OC(F)F)cc2c1)c3c[nH]nn3
Odanacatib,MK-0822,Merck,766811,603139-19-1,Capthepsin K,Investigational,DTP-110,CC(C)(F)C[C@H](N[C@@H](c1ccc(cc1)c2ccc(cc2)S(=O)(=O)C)C(F)(F)F)C(=O)NC3(CC3)C#N
,Hydrastinine HCl,,755892,6592-85-4,Cardiotonic,Investigational,DTP-110,CN1CCc2cc3OCOc3cc2C1O
,BIM-46187 ,Ipsen,760842,892546-37-1,Caspase-3,Investigational,DTP-110,N[C@@H](CSSC[C@H](N)C(=O)N1CCn2cc(nc2[C@@H]1CC3CCCCC3)c4ccccc4)C(=O)N5CCn6cc(nc6[C@@H]5CC7CCCCC7)c8ccccc8
,VBY-825,Virobay,782457,1310340-58-9,cathepsin,Investigational,DTP-110,CC[C@H](NC(=O)[C@H](CS(=O)(=O)CC1CC1)N[C@@H](c2ccc(F)cc2)C(F)(F)F)C(=O)C(=O)NC3CC3
Salinomycin,VS-507,Verastem,757437,53003-10-4,CD133,Investigational,DTP-110,CC[C@H]([C@H]1CC[C@H](C)[C@@H](O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(O[C@@]4(CC[C@](C)(O4)[C@H]5CC[C@](O)(CC)[C@H](C)O5)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)C(=O)O
,XL-413,Exelixis,775771,1169558-38-6,CDC7,Investigational,DTP-110,Clc1ccc2oc3C(=O)NC(=Nc3c2c1)C4CCCN4
Alvocidib,Flavopiridol,Sanofi,649890,131740-09-5,CDK,Investigational,DTP-110,
Seliciclib,CYC-202,CNRS,701554,186692-46-6,CDK,Investigational,DTP-110,CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1
Palbociclib,PD-0332991,Pfizer,758247,571190-30-2,CDK,Approved,DTP-103,CC(=O)C1=C(C)c2cnc(Nc3ccc(cn3)N4CCNCC4)nc2N(C5CCCC5)C1=O
,SB-1317,S*BIO,762673,1204918-72-8,CDK,Investigational,DTP-110,CN1C\C=C\CCOc2cccc(c2)c3ccnc(Nc4cccc(C1)c4)n3
Dinaciclib,MK-7965,Merck,764036,779353-01-4,CDK,Investigational,DTP-110,CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(nc12)N4CCCC[C@H]4CCO
, BMS-387032,BMS,767048,345627-92-1,CDK,Investigational,DTP-110,CC(C)(C)c1oc(CSc2cnc(NC(=O)C3CCNCC3)s2)nc1
Abemaciclib,LY-2835219,Eli Lilly,768073,1231929-97-7,CDK,Investigational,DTP-110,CCN1CCN(Cc2ccc(Nc3ncc(F)c(n3)c4cc(F)c5nc(C)n(C(C)C)c5c4)nc2)CC1
,R-547,Roche,773094,741713-40-6,CDK,Investigational,DTP-110,COc1ccc(F)c(F)c1C(=O)c2cnc(NC3CCN(CC3)S(=O)(=O)C)nc2N
,AT-7519,Astex,773394,844442-38-2,CDK,Investigational,DTP-110,Clc1cccc(Cl)c1C(=O)Nc2c[nH]nc2C(=O)NC3CCNCC3
Milciclib,PHA-848125,Pfizer,774830,802539-81-7,CDK,Investigational,DTP-110,CNC(=O)c1nn(C)c2c3nc(Nc4cccc(c4)N5CCN(C)CC5)ncc3CC(C)(C)c12
Roniciclib,BAY-1000394,Bayer,774911,1223498-26-7,CDK,Investigational,DTP-110,C[C@@H](O)[C@@H](C)Oc1nc(Nc2ccc(cc2)S(=N)(=O)C3CC3)ncc1C(F)(F)F
,AM-5992,Amgen,777879,1169694-98-7,CDK,Investigational,DPT-110,CN(CCO)C1CCN(CC1)c2ccc(Nc3ncc4c5ccnc(F)c5n(C6CCCC6)c4n3)nc2
Ribocclib,LEE-011,Novartis,778909,1211441-98-3,CDK,Investigational,DPT-110,CN(C)C(=O)c1cc2cnc(Nc3ccc(cn3)N4CCNCC4)nc2n1C5CCCC5
,AMG-925,Amgen,781514,1401033-86-0,CDK,Investigational,DPT-110,C[C@@H]1CC[C@H](CC1)n2c3cnccc3c4cnc(Nc5ccc6CN(CCc6n5)C(=O)CO)nc24
Dexrazoxone,,,169780,24584-09-6,Chemoprotective,Approved,DTP-103,C[C@@H](CN1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2
Amifostine,,AstraZeneca,296961,63717-27-1,Chemoprotective,Approved,DTP-103,NCCCNCCSP(=O)(O)O
,AZD-7762 ,AstraZeneca,757148,860352-01-8,Chk1,Investigational,DTP-110,NC(=O)Nc1cc(sc1C(=O)N[C@H]2CCCNC2)c3cccc(F)c3
,LY-2606368,Eli Lilly,758257,1234015-54-3,Chk1,Investigational,DTP-110,COc1cccc(OCCCN)c1c2cc(Nc3cnc(cn3)C#N)n[nH]2
Rabusertib,LY-2603618,Eli Lilly,761188,911222-45-2,Chk1,Investigational,DTP-110,Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]3CNCCO3)cn1
,PF-477736,Pfizer,763444,952021-60-2,Chk1,Investigational,DTP-110,Cn1cc(cn1)c2[nH]c3cc(NC(=O)[C@H](N)C4CCCCC4)cc5C(=O)NN=Cc2c35
,SCH-900776 ,Merck,764659,891494-63-6,Chk1,Investigational,DTP-110,Cn1cc(cn1)c2cnn3c(N)c(Br)c(nc23)C4CCCNC4
,BML-277,JNJ,741899,516480-79-8,Chk2,Investigational,DTP-110,NC(=O)c1ccc2[nH]c(nc2c1)c3ccc(Oc4ccc(Cl)cc4)cc3
,CCT-241533,Cancer Research Tech,776821,1262849-73-9,Chk2,Investigational,DTP-110,COc1cc2nc(nc(N[C@@H]3CNC[C@H]3C(C)(C)O)c2cc1OC)c4cc(F)ccc4O
Silmitasertib,CX-4945,Cylene,761193,1009820-21-6,CK2,Investigational,DTP-110,OC(=O)c1ccc2c(c1)nc(Nc3cccc(Cl)c3)c4ccncc24
,KPT-185,Karyopharm,772595,1333151-73-7,CRM1,Investigational,DTP-110,COc1cc(cc(c1)C(F)(F)F)c2ncn(\C=C/C(=O)OC(C)C)n2
,KPT-251,Karyopharm,773260,1388841-50-6,CRM1,Investigational,DTP-110,FC(F)(F)c1cc(cc(c1)C(F)(F)F)c2ncn(\C=C/c3ocnn3)n2
Selinexor,KPT-330,Karyopharm,780203,1393477-72-9,CRM1,Investigational,DPT-110,FC(F)(F)c1cc(cc(c1)C(F)(F)F)c2ncn(\C=C/C(=O)NNc3cnccn3)n2
,JNJ-28312141,JNJ,754345,1149939-55-8,CSF-1R,Investigational,DTP-110,CN(C)CC(=O)N1CCC(CC1)c2ccc(NC(=O)c3ncc(C#N)[nH]3)c(c2)C4=CCCCC4
,BLZ-945,Novartis,758006,953769-46-5,CSF-1R,Investigational,DTP-110,CNC(=O)c1cc(Oc2ccc3nc(N[C@@H]4CCCC[C@H]4O)sc3c2)ccn1
Plerixafor,"AMD-3100, SID-791; JLK-169",Johnson Matthey,761388,110078-46-1,CXCR4,Approved,DTP-103,C(N1CCCNCCNCCCNCC1)c2ccc(CN3CCCNCCNCCCNCC3)cc2
,AMD-070,Genzyme,775637,558447-26-0,CXCR4,Investigational,DPT-110,NCCCCN(Cc1nc2ccccc2[nH]1)[C@H]3CCCc4cccnc34
Celecoxib,CEP-33222; SC-58635; YM-177,Pfizer,719627,169590-42-5,Cyclooxygenase,Approved,DTP-103,Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F
Methoxsalen,8-MOP,Johnson & Johnson,45923,298-81-7,Cytochrome P450,Approved,DTP-103,COc1c2OC(=O)C=Cc2cc3ccoc13
Thiotepa,,Amgen,6396,52-24-4,Cytochrome P450 Oxidase,Approved,DTP-103,S=P(N1CC1)(N2CC2)N3CC3
Gemcitabine elaidate,CO-101,Clavis Pharma,765775,210829-30-4,Cytotoxic,Investigational,DTP-110,CCCCCCCC\C=C\CCCCCCCC(=O)OC[C@H]1O[C@@H](N2C=CC(=NC2=O)N)C(F)(F)[C@@H]1O
Methotrexate,CL-14377 ,Pfizer,740,59-05-2,DHFR,Approved,DTP-103,CN(Cc1cnc2nc(N)nc(N)c2n1)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
Pralatrexate,,Allos Therapeutics,754230,146464-95-1,DHFR,Approved,DTP-103,Nc1nc(N)c2nc(CC(CC#C)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)cnc2n1
Raltitrexed,ZD-1694,AstraZeneca,639186,112887-68-0,Dihydrofolate reductase,Investigational,DTP-110,CN(Cc1ccc2N=C(C)NC(=O)c2c1)c3ccc(s3)C(=O)N[C@@H](CCC(=O)O)C(=O)O
Mitomycin C,,BMS,26980,50-07-7,DNA Alkylating,Approved,DTP-103,CO[C@]12[C@H]3N[C@H]3CN1C4=C([C@H]2COC(=O)N)C(=O)C(=C(C)C4=O)N
Oxaliplatin,RP-54780¾,Sanofi,266046,61825-94-3,DNA alkylating,Approved,DTP-103,O=C1[O-][Pt+2]2([NH2+][C@@H]3CCCC[C@H]3[NH2+]2)[O-]C1=O
O-6-Benzylguanine,O6-BG,NCI,637037,19916-73-5,DNA alkyltransferase,Investigational,DTP-110,Nc1nc(OCc2ccccc2)c3nc[nH]c3n1
,Aminoflavone,,686288,165179-35-1,DNA damaging,Investigational,DTP-110,Cc1c(F)c(N)c2C(=O)C=C(Oc2c1F)c3ccc(N)c(F)c3
,AFP-464,Tigris,710464,468719-53-1,DNA damaging,Investigational,DTP-110,Cc1c(F)c(N)c2C(=O)C=C(Oc2c1F)c3ccc(NC(=O)[C@@H](N)CCCCN)c(F)c3
Doxorubicin,,Pfizer,123127,25316-40-9,DNA intercalating,Approved,DTP-103,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO
,FAU,Nascent Pharma.,678515,69123-94-0,DNA intercalating,Investigational,DTP-110,OCC1OC(C(F)C1O)N2C=CC(=O)NC2=O
Nelarabine,GW-506U78,GlaxoSmithKline,755985,121032-29-9,DNA intercalating,Approved,DTP-103,COc1nc(N)nc2c1ncn2[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O
,SGI-1027,Astex,783333,1020149-73-8,DNA methyltransferase,Investigational,DPT-110,Cc1cc(Nc2ccc(NC(=O)c3ccc(Nc4ccnc5ccccc45)cc3)cc2)nc(N)n1
,RG-108,Institute Biochmistry Biophysics (PAS),783334,48208-26-0,DNA methyltransferase,Investigational,DPT-110,OC(=O)[C@H](Cc1c[nH]c2ccccc12)N3C(=O)c4ccccc4C3=O
,IM-25,"Institute Molecular Biology, National Chung Cheng Univ",783360,91908-88-2,DNA methyltransferase,Investigational,DPT-110,COc1ccc(cc1OC)S(=O)(=O)N2CCNCC2
Cytarabine,U-19920A,Pfizer,63878,147-94-4,DNA polymerase,Approved,DTP-103,NC1=NC(=O)N(C=C1)C2OC(CO)C(O)C2O
Clofarabine,,Genzyme,606869,123318-82-1,DNA polymerase,Approved,DTP-103,Nc1nc(Cl)nc2c1ncn2C3OC(CO)C(O)C3F
Azacitidine,U-18496,Celgene Corporation,102816,320-67-2,DNA-alkyltransferase,Approved,DTP-103,NC1=NC(=O)N(C=N1)C2OC(CO)C(O)C2O
Dactinomycin,,Merck,3053,50-76-0,DNA-Directed RNA Polymerase,Approved,DTP-103,CC(C)[C@H]1NC(=O)[C@@H](NC(=O)C2=C(N)C(=O)C(=C3Oc4c(C)ccc(C(=O)N[C@H]5[C@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]6CCCN6C(=O)[C@H](NC5=O)C(C)C)c4N=C23)C)[C@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@@H]7CCCN7C1=O
,EPZ-5676,Epizyme,778365,1380288-87-8,DOT1L,Investigational,DTP-110,CC(C)N(C[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(N)ncnc23)C4CC(CCc5nc6cc(ccc6[nH]5)C(C)(C)C)C4
,EPZ-004777,Epizyme,780043,138466-77-5,DOT1L,Investigational,DTP-110,CC(C)N(CCCNC(=O)Nc1ccc(cc1)C(C)(C)C)C[C@H]2O[C@H]([C@H](O)[C@@H]2O)n3ccc4c(N)ncnc34
Gefitinib,ZD-1839,AstraZeneca,715055,184475-35-2,EGFR,Approved,DTP-103,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN4CCOCC4
Erlotinib,OSI-774; CP-358774,OSI,718781,183319-69-9,EGFR,Approved,DTP-103,COCCOc1cc2ncnc(Nc3cccc(c3)C#C)c2cc1OCCOC
Afatinib,BIBW-2992,Boehringer Ingelheim,750691,439081-18-2,EGFR,Approved,DTP-103,CN(C)C\C=C\C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]4CCOC4
,WZ-4002,Dana Farber,755927,1213269-23-8,EGFR,Investigational,DTP-110,COc1cc(ccc1Nc2ncc(Cl)c(Oc3cccc(NC(=O)C=C)c3)n2)N4CCN(C)CC4
Neratinib,PF-0528767,Pfizer,757439,698387-09-6,EGFR,Investigational,DTP-110,CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)\C=C\CN(C)C
Sapitinib,AZD-8931,AstraZeneca,758005,848942-61-0,EGFR,Investigational,DTP-110,CNC(=O)CN1CCC(CC1)Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC
,BMS-690514,BMS,760765,859853-30-8,EGFR,Investigational,DTP-110,
,BMS-599626,BMS,764135,714971-09-2,EGFR,Investigational,DTP-110,Cc1c(NC(=O)OC[C@@H]2COCCN2)cn3ncnc(Nc4ccc5c(cnn5Cc6cccc(F)c6)c4)c13
,Varlitinib,Array,764823,845272-21-1,EGFR,Investigational,DTP-110,
Dacomitinib,PF-299804,Pfizer,765888,1110813-31-4,EGFR,Investigational,DTP-110,COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)\C=C\CN4CCCCC4
,AEE-788 ,Novartis,765949,497839-62-0,EGFR,Investigational,DTP-110,CCN1CCN(Cc2ccc(cc2)c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)CC1
,XL-647,Exelixis,776762,781613-23-8,EGFR,Investigational,DTP-110,COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]4C[C@@H]5CN(C)C[C@@H]5C4
,AZD-9291,AstraZeneca,779217,1421373-65-0,EGFR,Investigational,DPT-110,COc1cc(N(C)CCN(C)C)c(NC(=O)C=C)cc1Nc2nccc(n2)c3cn(C)c4ccccc34
Rociletinib,CO-1686,Celgene,779405,1374640-70-6,EGFR,Investigational,DPT-110,COc1cc(ccc1Nc2ncc(c(Nc3cccc(NC(=O)C=C)c3)n2)C(F)(F)F)N4CCN(CC4)C(=O)C
Canertinib,PD-183805,Pfizer,780019,289499-45-2,EGFR,Investigational,DPT-110,Fc1ccc(Nc2ncnc3cc(OCCCN4CCOCC4)c(NC(=O)C=C)cc23)cc1Cl
,JNJ-26483327,JNJ,783249,807640-87-5,EGFR,Investigational,DTP-110,COc1cc2ncnc3Nc4cc(Br)ccc4CN(C)CCCCCOc1cc23
Poziotinib,HM-781-36B,Hanmi,783296,1092364-38-9,EGFR,Investigational,DTP-110,COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3F)c2cc1OC4CCN(CC4)C(=O)C=C
Lapatinib,GW-572016,GlaxoSmithKline,745750,388082-77-7,EGFR; erbB2,Approved,DTP-103,CS(=O)(=O)CCNCc1oc(cc1)c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2
,UNC-0638,UNC,764517,1255580-76-7,EHMT2,Investigational,DTP-110,COc1cc2c(NC3CCN(CC3)C(C)C)nc(nc2cc1OCCCN4CCCC4)C5CCCCC5
,BIX-01294,,777571,935693-62-2,EHMT2,Investigational,DPT-110,COc1cc2nc(nc(NC3CCN(Cc4ccccc4)CC3)c2cc1OC)N5CCCN(C)CC5
,BRD-4770,,777671,,EHMT2,Investigational,DTP-110,COC(=O)c1ccc2c(c1)nc(NC(=O)c3ccccc3)n2CCCc4ccccc4
Fulvestrant,ZD-9238,AstraZeneca,719276,129453-61-8,ER Antagonist,Approved,DTP-103,C[C@]12CC[C@H]3[C@@H]([C@H](CCCCCCCCCS(=O)CCCC(F)(F)C(F)(F)F)Cc4cc(O)ccc34)[C@@H]1CC[C@@H]2O
,ARRY-380,Array BioPharma,764581,937265-83-3,erbB2,Investigational,DTP-110,Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc5ccn6ncnc6c5
,CP-724714,Pfizer,780042,383432-38-0,erbB2,Investigational,DTP-110,COCC(=O)NC\C=C\c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1
,YK-4-279,Georgetown Univ,765436,1037184-44-3,ERG,Investigational,DTP-110,COc1ccc(cc1)C(=O)CC2(O)C(=O)Nc3c(Cl)ccc(Cl)c23
,SCH-772984,Merck,775636,942183-80-4,ERK,Investigational,DPT-110,O=C(CN1CC[C@H](C1)C(=O)Nc2ccc3[nH]nc(c4ccncc4)c3c2)N5CCN(CC5)c6ccc(cc6)c7ncccn7
,GDC-0994,Genetech,781343,1453848-26-4,Erk1/2,Investigational,DTP-110,Cn1nccc1Nc2nccc(n2)C3=CC(=O)N(C=C3)[C@H](CO)c4ccc(Cl)c(F)c4
,E-7438,Epizyme,777109,,EZH2,Investigational,DPT-110,CCN(C1CCOCC1)c2cc(cc(C(=O)NCC3=C(C)C=C(C)NC3=O)c2C)c4ccc(CN5CCOCC5)cc4
,GSK-126,GlaxoSmithKline,780041,1346574-57-9,EZH2,Investigational,DTP-110,CC[C@H](C)n1cc(C)c2c(cc(cc12)c3ccc(nc3)N4CCNCC4)C(=O)NCC5=C(C)C=C(C)NC5=O
,CPI-169,Constellation,782310,1450655-76-1,EZH2,Investigational,DTP-110,CCS(=O)(=O)N1CCC(CC1)C(C)n2c(C)c(C(=O)NCC3=C(OC)C=C(C)NC3=O)c4ccccc24
,EPZ-5687,,783332,1396772-26-1,EZH2,Investigational,DTP-110,CC1=CC(=C(CNC(=O)c2cc(cc3c2cnn3C4CCCC4)c5ccc(CN6CCOCC6)cc5)C(=O)N1)C
,PCI-27483,Celera,782579,871266-63-6,Factor VIIa,Investigational,DTP-110,NC(=N)c1ccc2[nH]c(nc2c1)c3cc(CC(=O)N[C@@H](CC(=O)O)C(=O)O)cc(c3O)c4cc(ccc4O)S(=O)(=O)N
,PF-562271,Pfizer,754356,717907-75-0,FAK,Investigational,DTP-110,CN(c1ncccc1CNc2nc(Nc3ccc4NC(=O)Cc4c3)ncc2C(F)(F)F)S(=O)(=O)C
Defactinib HCl,PF-04554878,Pfizer,778364,1073160-26-5,FAK,Investigational,DTP-110,CNC(=O)c1ccc(Nc2ncc(c(NCc3nccnc3N(C)S(=O)(=O)C)n2)C(F)(F)F)cc1
Defactinib,PF-04554878,Pfizer,782549,1073154-85-4,FAK,Investigational,DTP-110,CNC(=O)c1ccc(Nc2ncc(c(NCc3nccnc3N(C)S(=O)(=O)C)n2)C(F)(F)F)cc1
,VS-4718,,783102,1061353-68-1,FAK,Investigational,DPT-110,CNC(=O)c1ccccc1Nc2cc(Nc3ccc(cc3OC)N4CCOCC4)ncc2C(F)(F)F
Tipifarnib,R-115777,Johnson & Johnson,760444,192185-68-5,Farnesyltransferase,Investigational,DTP-110,CN1C(=O)C=C(c2cccc(Cl)c2)c3cc(ccc13)[C@](N)(c4ccc(Cl)cc4)c5cncn5C
Cerulenin,,Daiichi Sankyo,764755,17397-89-6,FAS,Investigational,DTP-110,C\C=C\C\C=C\CCC(=O)[C@H]1O[C@H]1C(=O)N
,C-75,John Hopkins,764756,218137-86-1,FAS,Investigational,DTP-110,CCCCCCCCC1OC(=O)C(=C)C1C(=O)O
,JNJ-54302833,JNJ,782125,1579514-16-1,FASN,Investigational,DTP-110,Cn1cc(cn1)c2ccc(cc2)c3ccc(cc3)C4=NC5(CC5)C(=O)N4C[C@@H]6CCN(C6)C(=O)C7CC7
,Astex FGF inhibitor,Astex,754361,1036991-21-5,FGFR,Investigational,DTP-110,Fc1ccc(cc1)c2ccn3c(cnc3c2)c4cccc(NC(=O)NCC(F)(F)F)c4
Infrigatinib,BGJ-398,Novartis,764487,872511-34-7,FGFR,Investigational,DTP-110,CCN1CCN(CC1)c2ccc(Nc3cc(ncn3)N(C)C(=O)Nc4c(Cl)c(OC)cc(OC)c4Cl)cc2
,PD-173074,Pfizer,766908,219580-11-7,FGFR,Investigational,DTP-110,CCN(CC)CCCCNc1ncc2cc(c(NC(=O)NC(C)(C)C)nc2n1)c3cc(OC)cc(OC)c3
,R-1530,Roche,767953,882531-87-5,FGFR,Investigational,DTP-110,COc1cc2Nc3n[nH]c(C)c3N=C(c4ccccc4Cl)c2cc1F
,LY-2874455,Eli Lilly,771750,1254473-64-7,FGFR,Investigational,DTP-110,C[C@@H](Oc1ccc2[nH]nc(\C=C\c3cnn(CCO)c3)c2c1)c4c(Cl)cncc4Cl
,JNJ-42756493,JNJ,781556,1346242-81-6,FGFR,Investigational,DTP-110,COc1cc(OC)cc(c1)N(CCNC(C)C)c2ccc3ncc(nc3c2)c4cnn(C)c4
,CH-5183284,Chugai,782363,1265229-25-1,FGFR,Investigational,DPT-110,Cc1nc2cc(ccc2[nH]1)n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N
,AZD-4547,AstraZeneca,764239,1035270-39-3,FGFR1,Investigational,DTP-110,COc1cc(CCc2cc(NC(=O)c3ccc(cc3)N4C[C@@H](C)N[C@@H](C)C4)n[nH]2)cc(OC)c1
Quizartinib,AC-220,Ambit Biosciences,756647,950769-58-1,Flt-3,Investigational,DTP-110,CC(C)(C)c1onc(NC(=O)Nc2ccc(cc2)c3cn4c5ccc(OCCN6CCOCC6)cc5sc4n3)c1
Tandutinib,MLN-518,Millennium,760841,387867-13-2,Flt-3,Investigational,DTP-110,COc1cc2c(ncnc2cc1OCCCN3CCCCC3)N4CCN(CC4)C(=O)Nc5ccc(OC(C)C)cc5
,ITRI-260,Industrial Institute,761879,1253836-17-7,Flt-3,Investigational,DTP-110,CN1CCN(CC1)c2ccc3[nH]c(nc3c2)C4=C5C=CC=CC=C5NC4=O
Fedratinib,SAR-302503,Sanofi,767600,936091-26-8,Flt-3,Investigational,DTP-110,Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc4cccc(c4)S(=O)(=O)NC(C)(C)C
,BPR1J-097,National Health Res Inst,767897,1327167-19-0,Flt-3,Investigational,DTP-110,CN1CCN(CC1)c2ccc(cc2)C(=O)Nc3cc(n[nH]3)c4cccc(NS(=O)(=O)c5ccccc5)c4
,VX-322,Vertex,771651,885610-66-2,Flt-3,Investigational,DTP-110,Nc1nc(Nc2ccc(cc2)[C@@H]3CC[C@H](CC3)N4CCOCC4)nn1c5ccccn5
Lestaurtinib,CEP-701,Kyowa Hakko Kirin,772196,111358-88-4,Flt-3,Investigational,DTP-110,C[C@]12O[C@H](C[C@]1(O)CO)n3c4ccccc4c5c6C(=O)NCc6c7c8ccccc8n2c7c35
Tempol,OT-674,Mitos Pharmaceuticals,142784,2226-96-2,free-radical scavenger,Investigational,DTP-110,
,PF-03084014 diastereomer 1,Pfizer,754348,865773-15-5,Gamma Secretase,Investigational,DTP-110,
,PF-03084014 diastereomer 2,Pfizer,755926,865773-15-5,Gamma Secretase,Investigational,DTP-110,
Semagacestat,LY-450139,Eli Lilly,755982,425386-60-3,Gamma secretase,Investigational,DTP-110,CC(C)[C@H](O)C(=O)N[C@@H](C)C(=O)N[C@@H]1C(=O)N(C)CCc2ccccc12
,RG-4733,Roche,756650,847925-91-1,Gamma Secretase,Investigational,DTP-110,CC(C)(C(=O)NCC(F)(F)C(F)(F)F)C(=O)N[C@@H]1C(=O)Nc2ccccc2c3ccccc13
Avagacestat,BMS-708163,BMS,761217,1146699-66-2,Gamma secretase,Investigational,DTP-110,NC(=O)[C@@H](CCC(F)(F)F)N(Cc1ccc(cc1F)c2nocn2)S(=O)(=O)c3ccc(Cl)cc3
,BMS-299897,BMS,762672,290315-45-6,Gamma Secretase,Investigational,DTP-110,
,MK-0752,Merk,762829,471905-41-6,Gamma Secretase,Investigational,DTP-110,OC(=O)CC[C@@H]1CC[C@](CC1)(c2cc(F)ccc2F)S(=O)(=O)c3ccc(Cl)cc3
,BMS-906024,BMS,780812,1401066-79-2,Gamma Secretase,Investigational,DTP-110,CN1C(=O)[C@@H](NC(=O)[C@H](CCC(F)(F)F)[C@H](CCC(F)(F)F)C(=O)N)N=C(c2ccccc2)c3ccccc13
Pelitrexol,AG-2037,Pfizer,767745,446022-33-9,GARTF,Investigational,DTP-110,Cc1cc(sc1CC[C@@H]2CNC3=C(C2)C(=O)NC(=N3)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O
,Pelitrexol isomer A,Pfizer,772290,,GARTF,Investigational,DTP-110,Cc1cc(sc1CCC2CNC3=C(C2)C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O
,Pelitrexol isomer B,Pfizer,772291,,GARTF,Investigational,DTP-110,Cc1cc(sc1CCC2CNC3=C(C2)C(=O)NC(=N3)N)C(=O)NC(CCC(=O)O)C(=O)O
,CB-839,Calithera Bioscience,783415,1439399-58-2,Glutaminase,Investigational,DTP-110,FC(F)(F)Oc1cccc(CC(=O)Nc2ccc(CCCCc3nnc(NC(=O)Cc4ccccn4)s3)nn2)c1
,CP-91149,Pfizer,761690,186392-40-5 ,Glycogen phosphorylase ,Investigational,DTP-110,CN(C)C(=O)[C@H](O)[C@H](Cc1ccccc1)NC(=O)c2cc3cc(Cl)ccc3[nH]2
6-Bromoindirubin-3'-Acetoxime,BIA,CNRS,764238,667463-85-6,GSK-3,Investigational,DTP-110,CC(=O)O\N=C/1\C(=C/2\C(=O)Nc3cc(Br)ccc23)\Nc4ccccc14
,AZD-2858,AstraZeneca,774901,1404225-38-2,GSK-3,Investigational,DPT-110,
,LY-2090314,Eli Lilly,772198,603288-22-8,GSK-beta,Investigational,DTP-110,Fc1cc2CN(CCn3cc(C4=C(C(=O)NC4=O)c5cnc6ccccn56)c(c1)c23)C(=O)N7CCCCC7
Ezatiostat,TLK-199,Telik,758484,286942-97-0 ,GSTP1,Investigational,DTP-110,CCOC(=O)[C@@H](N)CCC(=O)N[C@@H](CSCc1ccccc1)C(=O)N[C@@H](C(=O)OCC)c2ccccc2
Vorinostat,SAHA,Merck,701852,149647-78-9,HDAC,Approved,DTP-103,ONC(=O)CCCCCCC(=O)Nc1ccccc1
Depsipeptide,FK-228,Gloucester,754143,128517-07-7,HDAC,Approved,DTP-103,C\C=C\1/NC(=O)[C@H]2CSSCC\C=C\[C@H](CC(=O)N[C@H](C(C)C)C(=O)N2)OC(=O)[C@@H](NC1=O)C(C)C
Entinostat,MS-275,Syndax,756642,209783-80-2,HDAC,Investigational,DTP-110,Nc1ccccc1NC(=O)c2ccc(CNC(=O)OCc3cccnc3)cc2
Pracinostat,SB-939,S*BIO,758249,929016-96-6,HDAC,Investigational,DTP-110,CCCCc1nc2cc(\C=C\C(=O)NO)ccc2n1CCN(CC)CC
Belinostat,PXD-101, TopoTarget,758774,414864-00-9,HDAC,Approved,DTP-103,ONC(=O)\C=C\c1cccc(c1)S(=O)(=O)Nc2ccccc2
Quisinostat,JNJ-26481585,Johnson & Johnson,759657,875320-29-9,HDAC,Investigational,DTP-110,Cn1cc(CNCC2CCN(CC2)c3ncc(cn3)C(=O)NO)c4ccccc14
,4SC-202 ,4SC,759905,1186222-89-8,HDAC,Investigational,DTP-110,
Mocetinostat,MG-0103,MethylGene,760143,726169-73-9,HDAC,Investigational,DTP-110,Nc1ccccc1NC(=O)c2ccc(CNc3nccc(n3)c4cccnc4)cc2
Panobinostat,LBH-589,Novartis,761190,404950-80-7,HDAC,Approved,DTP-103,Cc1[nH]c2ccccc2c1CCNCc3ccc(\C=C\C(=O)NO)cc3
,ST-3595,Sigma-Tau,762153,918332-89-5,HDAC,Investigational,DTP-110,COc1ccc(cc1)c2ccc(\C=C\C(=O)NO)cc2
Abexinostat,PCI-24781,Celera,764136,783355-60-2,HDAC,Investigational,DTP-110,CN(C)Cc1c(oc2ccccc12)C(=O)NCCOc3ccc(cc3)C(=O)NO
Rocilinostat,ACY-1215,Dana Farber,767952,1316214-52-4,HDAC,Investigational,DTP-110,ONC(=O)CCCCCCNC(=O)c1cnc(nc1)N(c2ccccc2)c3ccccc3
,CUDC-907,Curis,771751,1339928-25-4,HDAC,Investigational,DTP-110,COc1ccc(cn1)c2nc(N3CCOCC3)c4sc(CN(C)c5ncc(cn5)C(=O)NO)cc4n2
,JNJ-16241199,Janssen,773264,604769-01-9,HDAC,Investigational,DTP-110,ONC(=O)c1cnc(nc1)N2CCN(CC2)S(=O)(=O)c3ccc4ccccc4c3
,3-Bromopyruvic acid,John Hopkins,62343,70-23-5,Hexokinase II,Investigational,DTP-110,OC(=O)C(=O)CBr
Lificguat,YC-1,Abbott,756879,170632-47-0,HIF 1,Investigational,DTP-110,OCc1oc(cc1)c2nn(Cc3ccccc3)c4ccccc24
,BAY-87-2243,Bayer,781016,1227158-85-1,HIF-1-alpha,Investigational,DPT-110,Cc1cc(nn1Cc2ccnc(c2)N3CCN(CC3)C4CC4)c5onc(n5)c6ccc(OC(F)(F)F)cc6
,XL-888,Exelixis,772351,1149705-71-4,Hsp-90,Investigational,DTP-110,CC[C@@H](C)Nc1cc(C(=O)NC2CC3CCC(C2)N3c4ccc(cn4)C(=O)C5CC5)c(C)cc1C(=O)N
,TAS-116,Taiho,780204,1260533-36-5,HSP-90,Investigational,DTP-110,CCc1cc(ccc1n2nc(C(C)C)c3c(ccnc23)n4cnc(c4)c5cnn(C)c5)C(=O)N
Tanespimycin,17-AAG,BMS,330507,75747-14-7,Hsp90,Investigational,DTP-110,CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)\C(=C\C=C/[C@H](OC)[C@@H](OC(=O)N)\C(=C\[C@H](C)[C@H]1O)\C)\C)C2=O
Alvespimycin,17-DMAG,BMS,707545,467214-21-7,Hsp90,Investigational,DTP-110,CO[C@@H]1C[C@H](C)CC2=C(NCCN(C)C)C(=O)C=C(NC(=O)\C(=C\C=C/[C@@H](OC)[C@H](OC(=O)N)\C(=C\[C@@H](C)[C@@H]1O)\C)\C)C2=O
Luminespib,AUY-922,Novartis,755762,747412-49-3,Hsp90,Investigational,DTP-110,CCNC(=O)c1noc(c2cc(C(C)C)c(O)cc2O)c1c3ccc(CN4CCOCC4)cc3
,CUDC-305,Curis,761194,1061318-81-7,Hsp90,Investigational,DTP-110,CN(C)c1cc2OCOc2cc1Sc3nc4c(N)nccc4n3CCNCC(C)(C)C
Onalespib,AT-13387 ,Astex,763579,912999-49-6,Hsp90,Investigational,DTP-110,CC(C)c1cc(C(=O)N2Cc3ccc(CN4CCN(C)CC4)cc3C2)c(O)cc1O
,MPC-3100,Myrexis,765395,958025-66-6,Hsp90,Investigational,DTP-110,
Ganetespib,STA-9090,Synta,765435,888216-25-9,Hsp90,Investigational,DTP-110,CC(C)c1cc(C2=NNC(=O)N2c3ccc4c(ccn4C)c3)c(O)cc1O
,PF-04929113,Pfizer,768509,908115-27-5,Hsp90,Investigational,DTP-110,CC1(C)CC(=O)c2c(C1)n(nc2C(F)(F)F)c3ccc(C(=O)N)c(N[C@@H]4CC[C@H](CC4)OC(=O)CN)c3
,PF-4942847,Pfizer,772885,1207961-33-8,Hsp90,Investigational,DTP-110,Cc1cc(Cl)cc(OCCn2cc(F)cn2)c1c3nc(N)nc4CN(Cc34)C(=O)NCC(C)(F)F
,CNF-2024,Conforma,773265,848695-25-0,Hsp90,Investigational,DTP-110,COc1c(C)cnc(Cn2cnc3c(Cl)nc(N)nc23)c1C
,SB-203580,GlaxoSmithKline,755772,152121-47-6,HSPBAP1,Investigational,DTP-110,CS(=O)c1ccc(cc1)c2nc(c3ccc(F)cc3)c([nH]2)c4ccncc4
,AT-406,Ascenta,764757,1071992-99-8,IAP,Investigational,DTP-110,CN[C@@H](C)C(=O)N[C@H]1CN(CC[C@H]2CC[C@H](N2C1=O)C(=O)NC(c3ccccc3)c4ccccc4)C(=O)CC(C)C
,GDC-0152,Roche,765898,873652-48-3,IAP,Investigational,DTP-110,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)Nc3snnc3c4ccccc4
Birinapant,TL-32711,TetraLogic,767128,1260251-31-7,IAP,Investigational,DTP-110,CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc2c([nH]c3cc(F)ccc23)c4[nH]c5cc(F)ccc5c4C[C@@H]6C[C@H](O)CN6C(=O)[C@H](CC)NC(=O)[C@H](C)NC
,LCL-161,Novartis,772868,1005342-46-0,IAP,Investigational,DTP-110,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2c3nc(cs3)C(=O)c4ccc(F)cc4
,CUDC-427,Genetech,781468,1446182-94-0,IAP,Investigational,DPT-110,CN[C@@H](C)C(=O)N[C@@H](C1CCCCC1)C(=O)N2CCC[C@H]2C(=O)Nc3sc(nc3c4ccccc4)c5occn5
,Agios Cmp 301,Agios,768539,1355324-87-6,IDH1,Investigational,DTP-110,Cc1ccccc1C(N(C(=O)CNc2ncccc2F)c3cccc(F)c3)C(=O)NC4CCCCC4
,IDH-C227,Agios,772564,1355324-14-9,IDH1,Investigational,DTP-110,Cc1ccccc1C(N(C(=O)CNc2ccc(cc2)C#N)c3cccc(F)c3)C(=O)NC4CCCCC4
,IDH-C35,Agios,773096,1355326-35-0,IDH1,Investigational,DTP-110,Cc1ccccc1C(N(C(=O)Cn2ccnc2C)c3cccc(F)c3)C(=O)NC4CCCCC4
,AGI-6780,,781409,1432660-47-3,IDH2,Investigational,DTP-110,FC(F)(F)c1cccc(NC(=O)Nc2cc(ccc2c3ccsc3)S(=O)(=O)NC4CC4)c1
Linsitinib,ASP-7487,OSI,756652,867160-71-2,IGF-1R,Investigational,DTP-110,C[C@@]1(O)C[C@@H](C1)c2nc(c3ccc4ccc(nc4c3)c5ccccc5)c6c(N)nccn26
,BMS-754807,BMS,758243,1001350-96-4,IGF-1R,Investigational,DTP-110,C[C@]1(CCCN1c2nc(Nc3cc(n[nH]3)C4CC4)c5cccn5n2)C(=O)Nc6ccc(F)nc6
,BMS-536924,BMS,761760,468740-43-4,IGF-1R,Investigational,DTP-110,Cc1cc(cc2[nH]c(nc12)C3=C(NC[C@@H](O)c4cccc(Cl)c4)C=CNC3=O)N5CCOCC5
,KHK Indazole,Kyowa Hakko Kogyo,761931,904897-64-9,IGF-1R,Investigational,DTP-110,O=C(Nc1ccccc1\C=C\c2n[nH]c3ccccc23)c4ccccc4
,GSK-1838705A,GlaxoSmithKline,766255,1186659-59-5,IGF-1R,Investigational,DTP-110,CNC(=O)c1c(F)cccc1Nc2nc(Nc3cc4N(CCc4cc3OC)C(=O)CN(C)C)nc5[nH]ccc25
,AEW-541,Novartis,767006,475489-16-8,IGF-1R,Investigational,DTP-110,Nc1ncnc2c1c(cn2[C@@H]3C[C@H](CN4CCC4)C3)c5cccc(OCc6ccccc6)c5
,ADW-742,Novartis,767746,475488-23-4,IGF-1R,Investigational,DTP-110,Nc1ncnc2c1c(cn2[C@@H]3C[C@@H](CN4CCCC4)C3)c5cccc(OCc6ccccc6)c5
,GSK-1904529A,GlaxoSmithKline,767951,1089283-49-7,IGF-1R,Investigational,DTP-110,CCc1cc(Nc2nccc(n2)c3c(nc4ccccn34)c5ccc(OC)c(c5)C(=O)Nc6c(F)cccc6F)c(OC)cc1N7CCC(CC7)N8CCN(CC8)S(=O)(=O)C
,XL-228,Exelixis,778366,952306-27-3,IGF-1R,Investigational,DTP-110,CC(C)c1cc(CNc2nc(Nc3cc([nH]n3)C4CC4)cc(n2)N5CCN(C)CC5)on1
,BP-1-102,University of Toronto,764037,1334493-07-0,IL-6,Investigational,DTP-110,CN(CC(=O)N(Cc1ccc(cc1)C2CCCCC2)c3ccc(C(=O)O)c(O)c3)S(=O)(=O)c4c(F)c(F)c(F)c(F)c4F
,ONX-0914,Onyx,762152,960374-59-8,Immunoproteasome,Investigational,DTP-110,COc1ccc(CC(NC(=O)[C@H](C)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)[C@@]4(C)CO4)cc1
,AVN-944,Vertex,767601,297730-17-7,IMPDH II,Investigational,DTP-110,CC[C@H](CC#N)OC(=O)N[C@@H](C)c1cccc(NC(=O)Nc2ccc(c(OC)c2)c3ocnc3)c1
,1-Methyl-[D]-tryptophan,NewLinkGenetics,721782,110117-83-4,"Indoleamine 2,3-dioxygenase",Investigational,DTP-110,
Picoplatin,AMD-473,Poniard,758490,181630-15-9,Inhibition of DNA replication,Investigational,DTP-110,Cc1cccc[n+]1[Pt+2](N)([ClH-])[ClH-]
Gemcitabine,LY-188011,Eli Lilly,613327,122111-03-9,Inhibition of DNA synthesis,Approved,DTP-103,NC1=NC(=O)N(C=C1)C2OC(CO)C(O)C2(F)F
Triapine,3-AP,Vion Pharmaceuticals,759096,143621-35-6 ,Inhibition of DNA synthesis,Investigational,DTP-110,NC(=S)N\N=C\c1ncccc1N
,E-7820,Esai,777573,,Integrin,Investigational,DPT-110,Cc1ccc(NS(=O)(=O)c2cccc(c2)C#N)c3[nH]cc(C#N)c13
Cilengitide,EMD-121974,Merck Serono,774651,188968-51-6,Integrin alpha,Investigational,DTP-110,CC(C)[C@@H]1N(C)C(=O)[C@@H](Cc2ccccc2)NC(=O)[C@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCN=C(N)N)NC1=O
,MK-0429,Merck,776790,227963-15-7,"Integrin alpha, beta-3",Investigational,DTP-110,COc1ccc(cn1)[C@H](CC(=O)O)N2CCN(CCCc3ccc4CCCNc4n3)C2=O
,WP-1034,MD Anderson,755981,857064-42-7,JAK,Investigational,DTP-110,
,AZD-1480,AstraZeneca,756648,935666-88-9,JAK,Investigational,DTP-110,C[C@H](Nc1ncc(Cl)c(Nc2cc(C)[nH]n2)n1)c3ncc(F)cn3
Gandotinib,LY-2784544,Eli Lilly,764820,1229236-86-5,JAK,Investigational,DTP-110,Cc1cc(Nc2cc(CN3CCOCC3)c4nc(C)c(Cc5ccc(Cl)cc5F)n4n2)[nH]n1
Momelotinib,CYT-387,YM Biosciences,767598,1056634-68-4,JAK,Investigational,DTP-110,O=C(NCC#N)c1ccc(cc1)c2ccnc(Nc3ccc(cc3)N4CCOCC4)n2
Tofacitinib,CP-690550,Pfizer,782351,477600-75-2,Jak,Investigational,DPT-110,C[C@@H]1CCN(C[C@@H]1N(C)c2ncnc3[nH]ccc23)C(=O)CC#N
Pacritinib,ONX-0803,S*BIO,759674,1138325-13-9,JAK2,Investigational,DTP-110,C(CN1CCCC1)Oc2ccc3cc2COC\C=C\CCOc4cccc(c4)C5=N\C(=N/3)\NC=C5
,BMS-911543,BMS,766821,1271022-90-2,JAK2,Investigational,DTP-110,CCn1c(cc2c1nc(Nc3cc(C)n(C)n3)c4ncn(C)c24)C(=O)N(C5CC5)C6CC6
,XL-019,Exelixis,772887,945750-13-0,JAK2,Investigational,DTP-110,O=C(Nc1ccc(cc1)c2ccnc(Nc3ccc(cc3)N4CCOCC4)n2)C5CCCN5
,SB-1578,S*BIO,772920,937273-04-6,JAK2,Investigational,DTP-110,C(CN1CCCC1)Oc2ccc3Nc4nccc(n4)c5oc(COC\C=C\COCc2c3)cc5
,SP-600125,Celgene,755773,12956-6,JNK,Investigational,DTP-110,O=C1c2ccccc2c3n[nH]c4cccc1c34
,LOR-253,Lorus,763832,916151-99-0,KLF4,Investigational,DTP-110,Cc1[nH]c2cc(F)ccc2c1c3nc4c5cccnc5c6ncccc6c4[nH]3
Ispinesib,CK-0238273,Cytokinetics,755386,336113-53-2,KSP,Investigational,DTP-110,CC(C)[C@@H](N(CCCN)C(=O)c1ccc(C)cc1)C2=Nc3cc(Cl)ccc3C(=O)N2Cc4ccccc4
,EMD-534085,Merck KGaA,763564,858668-07-2,KSP,Investigational,DTP-110,CN(C)CCNC(=O)NC[C@H]1CC[C@H]2[C@@H](Nc3ccc(cc3[C@H]2O1)C(F)(F)F)c4ccccc4
Litronesib,LY-2523355,Eli Lilly,765673,1219032-64-0,KSP,Investigational,DTP-110,CCCCCCNC(=O)c1nc(oc1Cc2ccc(OP(=O)(O)O)cc2)c3ccccc3
,ARQ-621,Arqule,771644,1095253-39-6,KSP,Investigational,DTP-110,NCCCN([C@H](CC#C)C1=Nc2cc(Cl)ccc2C(=O)N1Nc3ccccc3)C(=O)c4cccc(Cl)c4F
,ARRY-520 (isomer A),Array BioPharma,772254,885060-09-3,KSP,Investigational,DTP-110,CON(C)C(=O)N1N=C(SC1(CCCN)c2ccccc2)c3cc(F)ccc3F
,ARRY-520 (isomer B),Array BioPharma,772255,885060-09-3,KSP,Investigational,DTP-110,CON(C)C(=O)N1N=C(SC1(CCCN)c2ccccc2)c3cc(F)ccc3F
,SB-743921,GlaxoSmithKline,773261,940929-33-9,KSP,Investigational,DTP-110,CC(C)C(N(CCCN)C(=O)c1ccc(C)cc1)C2=C(Cc3ccccc3)C(=O)c4ccc(Cl)cc4O2
,MK-0731,Merck,780965,845256-65-7,KSP; Eg5,Investigational,DTP-110,CN([C@H]1CCN(C)C[C@H]1F)C(=O)N2CC(=C[C@@]2(CO)c3ccccc3)c4cc(F)ccc4F
,LDHA Cmp 33,AstraZeneca,773174,1370290-34-8,LDHA,Investigational,DTP-110,Cc1nc2ccc(NC(=O)CCNC(=O)CCCc3ccc(CC(C(=O)O)C(=O)O)cc3)cc2s1
,LDHA Cmp 35,AstraZeneca,775018,1370290-53-1,LDHA,Investigational,DTP-110,CCOC(=O)C(Cc1ccc(CCCC(=O)NCCC(=O)Nc2ccc3nc(C)sc3c2)cc1)C(=O)OCC
,CT-32228,Cell Therapeutics,762419,521064-34-6,LPAAT-beta,Investigational,DTP-110,Cc1ccc(Cl)cc1c2nc(N)nc(Nc3ccc(Br)cc3)n2
Bafetinib, CNS-9,CytRx,773263,859212-16-1,Lyn,Investigational,DTP-110,CN(C)[C@H]1CCN(Cc2ccc(cc2C(F)(F)F)C(=O)Nc3ccc(C)c(Nc4ncc(cn4)c5cncnc5)c3)C1
,JZL-184,VCU,763094,1101854-58-3,MAGL,Investigational,DTP-110,OC(C1CCN(CC1)C(=O)Oc2ccc(cc2)[N+](=O)[O-])(c3ccc4OCOc4c3)c5ccc6OCOc6c5
,JZL-195,,763527,1210004-12-8,MAGL,Investigational,DTP-110,[O-][N+](=O)c1ccc(OC(=O)N2CCN(Cc3cccc(Oc4ccccc4)c3)CC2)cc1
,(+)=Marinopyrrole A,Scripps,781008,1227962-62-0,Mcl-1,Investigational,DTP-110,Oc1ccccc1C(=O)c2[nH]c(Cl)c(Cl)c2n3c(Cl)c(Cl)cc3C(=O)c4ccccc4O
,JNJ-27291199,3-Dimensional,754358,787632-66-0,MDM2,Investigational,DTP-110,C[C@@H](N1[C@H](C(=O)N(CCCN2CCN(C)CC2)c3ccc(I)cc3C1=O)c4ccc(Cl)cc4)c5ccc(Cl)cc5N
,MI-219,University of Michigan,754360,1201143-87-4,MDM2,Investigational,DTP-110,CC(C)(C)C[C@H]1NC([C@H](c2cccc(Cl)c2)[C@@]13C(=O)Nc4cc(Cl)c(F)cc34)C(=O)NCC[C@H](O)CO
(+/-)-Nutlin-3,,Roche,756875,548472-68-0,MDM2,Investigational,DTP-110,COc1ccc(C2=N[C@H]([C@H](N2C(=O)N3CCNC(=O)C3)c4ccc(Cl)cc4)c5ccc(Cl)cc5)c(OC(C)C)c1
(-)-Nutlin-3,,Roche,756876,675576-98-4,MDM2,Investigational,DTP-110,COc1ccc(C2=N[C@H]([C@H](N2C(=O)N3CCNC(=O)C3)c4ccc(Cl)cc4)c5ccc(Cl)cc5)c(OC(C)C)c1
, 1st Precursur Intermediate to TDP 665759,,756877,898222-46-3,MDM2,Investigational,DTP-110,C[C@@H](N1[C@@H](C(=O)Nc2ccc(I)cc2C1=O)c3ccc(Cl)cc3)c4ccc(Cl)cc4[N+](=O)[O-]
,2nd Precursur Intermediate to TDP 665759,,756878,,MDM2,Investigational,DTP-110,C[C@@H](N1[C@H](C(=Nc2ccc(I)cc2C1=O)OCCCN3CCN(C)CC3)c4ccc(Cl)cc4)c5ccc(Cl)cc5[N+](=O)[O-]
(+)-Nutlin-3,,Roche,763443,675576-97-3,MDM2,Investigational,DTP-110,COc1ccc(C2=N[C@H]([C@H](N2C(=O)N3CCNC(=O)C3)c4ccc(Cl)cc4)c5ccc(Cl)cc5)c(OC(C)C)c1
,RG-7112,Roche,771531,,MDM2,Investigational,DTP-110,CCOc1cc(ccc1C2=N[C@@](C)(c3ccc(Cl)cc3)[C@](C)(N2C(=O)N4CCN(CCS(=O)(=O)C)CC4)c5ccc(Cl)cc5)C(C)(C)C
,RG-7388,Roche,779404,1229705-06-9,MDM2,Investigational,DTP-110,COc1cc(ccc1NC(=O)[C@@H]2N[C@@H](CC(C)(C)C)[C@@](C#N)([C@H]2c3cccc(Cl)c3F)c4ccc(Cl)cc4F)C(=O)O
,MI-773,Michigan,781009,1303607-07-9,MDM2,Investigational,DTP-110,CC(C)(C)C[C@H]1N[C@H]([C@H](c2cccc(Cl)c2F)[C@@]13C(=O)Nc4cc(Cl)ccc34)C(=O)N[C@@H]5CC[C@@H](O)CC5
,AMG-232,Amgen,781515,1352066-68-2,MDM2,Investigational,DPT-110,CC(C)[C@@H](CS(=O)(=O)C(C)C)N1[C@@H]([C@H](C[C@](C)(CC(=O)O)C1=O)c2cccc(Cl)c2)c3ccc(Cl)cc3
,CGM-097,Novartis,783015,1313363-54-0,MDM2,Investigational,DTP-110,COc1cc2CC(=O)N([C@@H](c3ccc(Cl)cc3)c2cc1OC(C)C)c4ccc(cc4)N(C)C[C@@H]5CC[C@H](CC5)N6CCN(C)C(=O)C6
,PD-98059,Pfizer,679828,167869-21-8,MEK,Investigational,DTP-110,COc1cccc(C2=CC(=O)c3ccccc3O2)c1N
Selumetinib,AZD-6244,AstraZeneca,741078,606143-52-6,MEK,Investigational,DTP-110,Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(cc12)C(=O)NOCCO
Pimasertib,AS-703026,Santhera,755763,1236699-92-5 ,MEK,Investigational,DTP-110,OC[C@@H](O)CNC(=O)c1ccncc1Nc2ccc(I)cc2F
Trametinib,GSK-1120212,GlaxoSmithKline,758246,1204531-25-8 ,MEK,Approved,DTP-103,CN1C(=O)C(=C2N(C(=O)N(C3CC3)C(=O)C2=C1Nc4ccc(I)cc4F)c5cccc(NC(=O)C)c5)C
,RO-5126766,Roche,758248,946128-88-7,MEK,Investigational,DTP-110,CNS(=O)(=O)Nc1nccc(CC2=C(C)c3ccc(Oc4ncccn4)cc3OC2=O)c1F
,TAK-733,Takeda,761215,1035555-63-5,MEK,Investigational,DTP-110,
,RG-7167,Roche; Chugai,762521,874101-00-5,MEK,Investigational,DTP-110,OCCONC(=O)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc3ccc(I)cc3F
,ARRY-162,Array BioPharma,764042,1201685-05-3,MEK,Investigational,DTP-110,Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(cc12)C(=O)NOCCO
,PD-184352,Pfizer,765695,212631-79-3,MEK,Investigational,DTP-110,Fc1ccc(C(=O)NOCC2CC2)c(Nc3ccc(I)cc3Cl)c1F
Refametinib,BAY-86-9766,Bayer,765866,923032-37-5,MEK,Investigational,DTP-110,COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C3(CC(O)CO)CC3
Cobimetinib (isomer 1),XL-518 (isomer 1),Exelixis,768068,934660-93-2,MEK,Investigational,DTP-110,OC1(CN(C1)C(=O)c2ccc(F)c(F)c2Nc3ccc(I)cc3F)[C@@H]4CCCCN4
Cobimetinib (isomer 2),XL-518 (isomer 2),Exelixis,768069,934660-93-2,MEK,Investigational,DTP-110,OC1(CN(C1)C(=O)c2ccc(F)c(F)c2Nc3ccc(I)cc3F)[C@H]4CCCCN4
,AZD-8330,AstraZeneca,772563,869357-68-6,MEK,Investigational,DTP-110,CN1C(=O)C(=CC(=C1Nc2ccc(I)cc2F)C(=O)NOCCO)C
,GDC-0623,Roche,778590,1168091-68-6,MEK,Investigational,DTP-110,OCCONC(=O)c1ccc2cncn2c1Nc3ccc(I)cc3F
,PD-0325901,Pfizer,755770,391210-10-9,MEK ,Investigational,DTP-110,OC[C@@H](O)CONC(=O)c1ccc(F)c(F)c1Nc2ccc(I)cc2F
,JNJ-47117096,Janssen,783272,,MELK,Investigational,DPT-110,COc1cc(ccc1C(=O)Nc2ccc3CCNCCc3c2)c4cn[nH]c4
Paclitaxel,BMS-181339 ; ANX-513; SDP-013,BMS,125973,33069-62-4,Microtubule,Approved,DTP-103,CC(=O)O[C@H]1C(=O)[C@]2(C)[C@@H](O)C[C@H]3OC[C@@]3(OC(=O)C)[C@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7)C(=C1C5(C)C)C
Ixabepilone,BMS-247550,Bristol-Myers Squibb,747973,219989-84-1,Microtubule,Approved,DTP-103,
,BAL-101553,Basilea Pharmaceutica,764608,1263384-43-5,Microtubule,Investigational,DTP-110,NCCCC[C@H](N)C(=O)Nc1ccc(cc1)C(=O)Cn2c(nc3ccccc23)c4nonc4NCCC#N
Vinblastine,,Eli Lilly,49842,143-67-9,Microtubule ,Approved,DTP-103,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
Rapamycin,,Wyeth,226080,53123-88-9,mTor,Approved,DTP-103,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(/C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1O
Temsirolimus,CCI-779,Wyeth,683864,162635-04-3,mTor,Approved,DTP-103,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(/C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1OC(=O)C(C)(CO)CO
Everolimus ,RAD-101,Novartis,733504,159351-69-6,mTor,Approved,DTP-103,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(/C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1OCCO
Dactolisib,BEZ-235,Novartis,751249,915019-65-7,mTor,Investigational,DTP-110,CN1C(=O)N(c2ccc(cc2)C(C)(C)C#N)c3c1cnc4ccc(cc34)c5cnc6ccccc6c5
Deforolimus,MK-8669 ,Merck,757440,572924-54-0,mTor,Investigational,DTP-110,CO[C@@H]1C[C@H](C[C@@H](C)[C@@H]2CC(=O)[C@H](C)\C=C(/C)\[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)\C=C\C=C\C=C(/C)\[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1OP(=O)(C)C
,PF-05212384,Pfizer,758256,1197160-78-3,mTor,Investigational,DTP-110,CN(C)C1CCN(CC1)C(=O)c2ccc(NC(=O)Nc3ccc(cc3)c4nc(nc(n4)N5CCOCC5)N6CCOCC6)cc2
,AZD-8055,AstraZeneca,758871,1009298-09-2,mTor,Investigational,DTP-110,
,OSI-027,OSI,759660,1187559-66-5,mTor,Investigational,DTP-110,COc1cccc2cc([nH]c12)c3nc(C4CCC(CC4)C(=O)O)n5ncnc(N)c35
Apitolisib,GDC-0980,Roche,764091,1256580-46-7,mTor,Investigational,DTP-110,C[C@H](O)C(=O)N1CCN(Cc2sc3c(nc(nc3c2C)c4cnc(N)nc4)N5CCOCC5)CC1
,PP-242,UCSF,764515,1092351-67-1,mTor,Investigational,DTP-110,CC(C)n1nc(c2cc3cc(O)ccc3[nH]2)c4c(N)ncnc14
,INK-128,Intellikine,764658,1224844-38-5,mTor,Investigational,DTP-110,CC(C)n1nc(c2ccc3oc(N)nc3c2)c4c(N)ncnc14
,AZD-2014,AstraZeneca,767189,1009298-59-2,mTor,Investigational,DTP-110,CNC(=O)c1cccc(c1)c2ccc3c(nc(nc3n2)N4CCOC[C@@H]4C)N5CCOC[C@@H]5C
,RG-7603,Roche,771532,1207360-89-1,mTor,Investigational,DTP-110,CCNC(=O)Nc1ccc(cc1)c2nc3CN(CCc3c(n2)N4CCOC[C@@H]4C)C5COC5
,Torin2,Dana Farber,775727,1223001-51-1,mTor,Investigational,DTP-110,Nc1ccc(cn1)c2ccc3ncc4C=CC(=O)N(c5cccc(c5)C(F)(F)F)c4c3c2
,AZ-505,AstraZeneca,780404,1035227-44-1,N-Lysine Methyltransferase,Investigational,DPT-110,Oc1ccc(CCNCCN(C2CCCCC2)C(=O)CCNCCc3ccc(Cl)c(Cl)c3)c4OCC(=O)Nc14
Pevonedistat,MLN-4924,Millennium,761192,1160295-21-5,NAE,Investigational,DTP-110,NS(=O)(=O)OC[C@@H]1C[C@H](C[C@@H]1O)n2ccc3c(NC4CCc5ccccc45)ncnc23
,GNE-617,Forma,779407,1362154-70-8,NAMPTase,Investigational,DPT-110,Fc1cc(F)cc(c1)S(=O)(=O)c2ccc(CNC(=O)c3ccc4nccn4c3)cc2
Streptozocin,U-9889,Pfizer,85998,18883-66-4,Nitroso,Approved,DTP-103,CN(N=O)C(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO
Daporinad,AP0-866,Astellas,760442,658084-64-1,NMPRTase,Investigational,DTP-110,O=C(NCCCCC1CCN(CC1)C(=O)c2ccccc2)\C=C\c3cccnc3
Daporinad,AP0-866,Astellas,777194,658084-64-1,NMPRTase,Investigational,DTP-110,O=C(NCCCCC1CCN(CC1)C(=O)c2ccccc2)\C=C\c3cccnc3
Teglarinad,EB-1627,Gemin X,761189,432037-57-5,NMRPRTase,Investigational,DTP-110,
,ARRY-614,Array BioPharma,778367,,p38,Investigational,DTP-110,Cc1ccc(cc1)n2nc(cc2NC(=O)NCc3cc(F)ccc3Oc4ccc5c(cnn5CCO)c4)C(C)(C)C
,SB-239063,GlaxoSmithKline,756653,193551-21-2,p38 MAPK,Investigational,DTP-110,COc1nccc(n1)c2c(ncn2C3CCC(O)CC3)c4ccc(F)cc4
,LY-2228820,Eli Lilly,766820,862507-23-1,p38 MAPK,Investigational,DTP-110,CC(C)(C)Cn1c(N)nc2ccc(nc12)c3nc([nH]c3c4ccc(F)cc4)C(C)(C)C
,VX-702,Vertex,775665,745833-23-2,p38 MAPK,Investigational,DTP-110,NC(=O)N(c1ccc(C(=O)N)c(n1)c2ccc(F)cc2F)c3c(F)cccc3F
Talmapimod,SCIP-469,Scios,777446,309913-83-5,p38 MAPK,Investigational,DTP-110,C[C@@H]1CN(Cc2ccc(F)cc2)[C@@H](C)CN1C(=O)c3cc4c(cn(C)c4cc3Cl)C(=O)C(=O)N(C)C
,PF-03758309,Pfizer,781470,898044-15-0,PAK4,Investigational,DPT-110,CN(C)C[C@@H](NC(=O)N1Cc2c(Nc3nc(C)nc4ccsc34)n[nH]c2C1(C)C)c5ccccc5
,E-7449,Eisai,783107,,Parp,Investigational,DTP-110,O=C1NNc2nc(CN3Cc4ccccc4C3)nc5cccc1c25
Iniparib,BSI-201,Sanofi,752493,160003-66-7,Parp-1,Investigational,DTP-110,NC(=O)c1ccc(I)c(c1)[N+](=O)[O-]
Veliparib,ABT-888,Abbott,752840,912444-00-9,Parp-1,Investigational,DTP-110,C[C@@]1(CCCN1)c2nc3c(cccc3[nH]2)C(=O)N
Olaparib,AZD-2281,AstraZeneca,753686,763113-22-0,Parp-1,Approved,DTP-103,Fc1ccc(CC2=NNC(=O)c3ccccc23)cc1C(=O)N4CCN(CC4)C(=O)C5CC5
Niraparib,MK-4827,Merck,754355,1038915-60-4,Parp-1,Investigational,DTP-110,NC(=O)c1cccc2cn(nc12)c3ccc(cc3)[C@@H]4CCCNC4
Rucaparib,PF-01367338,Pfizer,756644,917828-48-9,Parp-1,Investigational,DTP-110,CNCc1ccc(cc1)c2[nH]c3cc(F)cc4C(=O)NCCc2c34
,BMN-673 (racemate),BioMarin,765396,1207454-56-5,Parp-1,Investigational,DTP-110,
Talazoparib,BMN-673,BioMarin,767125,1207456-01-6,Parp-1,Investigational,DTP-110,Cn1ncnc1[C@@H]2[C@H](Nc3cc(F)cc4C(=O)NN=C2c34)c5ccc(F)cc5
,BMN-673 (inactive enantiomer),BioMarin,767533,1207456-00-5,Parp-1,Investigational,DTP-110,Cn1ncnc1[C@H]2[C@@H](Nc3cc(F)cc4C(=O)NN=C2c34)c5ccc(F)cc5
,CEP-9722,Cephalon,768593,916574-83-9,Parp-1,Investigational,DTP-110,COc1cccc2[nH]c3c4CCCc4c5C(=O)N(CN6CCN(C)CC6)C(=O)c5c3c12
,AZD-2461,AstraZeneca,773230,1174043-16-3,Parp-1,Investigational,DTP-110,COC1CCN(CC1)C(=O)c2cc(CC3=NNC(=O)c4ccccc34)ccc2F
,Deltarasin,Max-Planck,779408,1440898-61-2,PDE-delta,Investigational,DTP-110,C(Oc1ccc(cc1)c2nc3ccccc3n2Cc4ccccc4)[C@H](C5CCNCC5)n6c(nc7ccccc67)c8ccccc8
 Crenolanib,CP-868596,Pfizer,763526,670220-88-9,PDGFR,Investigational,DTP-110,CC1(COc2ccc3c(c2)ncn3c4ccc5cccc(N6CCC(N)CC6)c5n4)COC1
Linifanib,ABT-869,Abbott,764237,796967-16-3,PDGFR,Investigational,DTP-110,Cc1ccc(F)c(NC(=O)Nc2ccc(cc2)c3cccc4[nH]nc(N)c34)c1
Axitinib,AG-013736 ,Pfizer,757441,319460-85-0,PDGFR; VEGFR,Approved,DTP-103,CNC(=O)c1ccccc1Sc2ccc3c(\C=C\c4ccccn4)n[nH]c3c2
,OSU-03012 ,Ohio State,756657,742112-33-0,PDK-1,Investigational,DTP-110,NCC(=O)Nc1ccc(cc1)n2nc(cc2c3ccc4c(ccc5ccccc45)c3)C(F)(F)F
,OSU-03013,Ohio State,756658,742112-34-1,PDK-1,Investigational,DTP-110,NC(=N)Nc1ccc(cc1)n2nc(cc2c3ccc4c(ccc5ccccc45)c3)C(F)(F)F
,BX-912,Berlex,758485,702674-56-4,PDK-1,Investigational,DTP-110,Brc1cnc(Nc2cccc(NC(=O)N3CCCC3)c2)nc1NCCc4c[nH]cn4
,GSK-2334470,GlaxoSmithKline,759658,1227911-45-6,PDK-1,Investigational,DTP-110,CNc1nc(cc(n1)c2ccc3c(N)n[nH]c3c2)N4C[C@@H](CC[C@@H]4C)C(=O)NC5CCCCC5
, GSK-2606414 ,GlaxoSmithKline,781627,1337531-36-8,PERK,Investigational,DPT-110,Cn1cc(c2ccc3N(CCc3c2)C(=O)Cc4cccc(c4)C(F)(F)F)c5c(N)ncnc15
Aminolevulinic acid,,,18509,106-60-5,Photosensitizer,Approved,DTP-103,NCC(=O)CCC(=O)O
,Wortmannin,Sigma Aldrich,221019,19545-26-7,pI3K,Investigational,DTP-110,COC[C@H]1OC(=O)c2coc3C(=O)C4=C([C@@H](C[C@@]5(C)[C@H]4CCC5=O)OC(=O)C)[C@]1(C)c23
Sonolisib,PX-866,,722134,502844-51-1,PI3K,Investigational,DTP-110,COC[C@H]1OC(=O)\C(=C/N(CC=C)CC=C)\C2=C(O)C(=O)C3=C([C@@H](C[C@@]4(C)[C@H]3CCC4=O)OC(=O)C)[C@@]12C
,XL-147,Exelixis,754351,956958-53-5,pI3K,Investigational,DTP-110,Cc1ccc(cc1)S(=O)(=O)Nc2nc3ccccc3nc2Nc4ccc5nsnc5c4
Buparlisib,BKM-120,Novartis,754353,944396-07-0,pI3K,Investigational,DTP-110,Nc1cc(c(cn1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)C(F)(F)F
Pictilisib,GDC-0941,Roche,755385,957054-30-7,pI3K,Investigational,DTP-110,CS(=O)(=O)N1CCN(Cc2cc3nc(nc(N4CCOCC4)c3s2)c5cccc6[nH]ncc56)CC1
,LY-294002,Eli Lilly,755769,154447-36-6,pI3K,Investigational,DTP-110,O=C1C=C(Oc2c1cccc2c3ccccc3)N4CCOCC4
Idelalisib,CAL-101,Icos,759224,870281-82-6,PI3K,Approved,DTP-103,CC[C@H](Nc1ncnc2[nH]cnc12)C3=Nc4cccc(F)c4C(=O)N3c5ccccc5
,PI-103,Astellas,759676,371935-74-9,PI3K,Investigational,DTP-110,Oc1cccc(c1)c2nc(N3CCOCC3)c4oc5ncccc5c4n2
Copanlisib,BAY-80-6946 ,Bayer,760443,1032568-63-0,PI3K,Investigational,DTP-110,COc1c(OCCCN2CCOCC2)ccc3C4=NCCN4C(=Nc13)NC(=O)c5cnc(N)nc5
,PF-04691502,Pfizer,760536,1013101-36-4,pI3K,Investigational,DTP-110,COc1ccc(cn1)C2=Cc3c(C)nc(N)nc3N([C@@H]4CC[C@H](CC4)OCCO)C2=O
,CH-5132799 ,Chugai,762382,1007207-67-1,PI3K,Investigational,DTP-110,CS(=O)(=O)N1CCc2c1nc(nc2c3cnc(N)nc3)N4CCOCC4
,GSK-2126458,GSK,764092,1086062-66-9,PI3K,Investigational,DTP-110,COc1ncc(cc1NS(=O)(=O)c2ccc(F)cc2F)c3ccc4nccc(c5ccnnc5)c4c3
,ZSTK-474,Zenyaku Kogyo,764516,475110-96-4,PI3K,Investigational,DTP-110,FC(F)c1nc2ccccc2n1c3nc(nc(n3)N4CCOCC4)N5CCOCC5
,BYL-719,Novartis,765974,1217486-61-7,PI3K,Investigational,DTP-110,Cc1nc(NC(=O)N2CCC[C@H]2C(=O)N)sc1c3ccnc(c3)C(C)(C)C(F)(F)F
Enzastaurin,LY-317615,Eli Lilly,767124,170364-57-5,PI3K,Investigational,DTP-110,Cn1cc(C2=C(C(=O)NC2=O)c3cn(C4CCN(Cc5ccccn5)CC4)c6ccccc36)c7ccccc17
,XL-765,Exelixis,768100,1349796-36-6,PI3K,Investigational,DTP-110,COc1cc(Nc2nc3ccccc3nc2NS(=O)(=O)c4ccc(NC(=O)c5ccc(C)c(OC)c5)cc4)cc(OC)c1
,GSK-2636771,GlaxoSmithKline,768508,1372540-25-4,PI3K,Investigational,DTP-110,Cc1c(Cn2c(C)nc3c(cc(cc23)N4CCOCC4)C(=O)O)cccc1C(F)(F)F
,INK-1197,Infinity,772469,1201438-56-3,pI3K,Investigational,DTP-110,C[C@H](Nc1ncnc2[nH]cnc12)C3=Cc4cccc(Cl)c4C(=O)N3c5ccccc5
,BGT-226,Novartis,773095,1245537-68-1,PI3K,Investigational,DTP-110,COc1ccc(cn1)c2ccc3ncc4N(C)C(=O)N(c5ccc(N6CCNCC6)c(c5)C(F)(F)F)c4c3c2
,PI-103 HCl,Astellas,776996,,PI3K,Investigational,DPT-110,Oc1cccc(c1)c2nc(N3CCOCC3)c4oc5ncccc5c4n2
,VS-5584,Verastem,778810,1246560-33-7,PI3K,Investigational,DPT-110,CC(C)n1c(C)nc2c(nc(nc12)N3CCOCC3)c4cnc(N)nc4
,AMG-511,Amgen,782122,1253573-53-3,PI3K,Investigational,DTP-110,COc1ncc(Nc2ncc(cc2c3nc(C)nc(N)n3)[C@@H](C)N4CCN(CC4)S(=O)(=O)C)cc1F
,PWT-33597,Pathway,782362,1246203-32-6,PI3K,Investigational,DTP-110,COc1cccc2c1nc(C(F)F)n2c3nc(nc(n3)c4ccc(NS(=O)(=O)CCN(C)C)cc4)N5CCOCC5
Taselisib,GDC-0032,Roche,777425,,pI3K alpha,Investigational,DTP-110,CC(C)n1nc(C)nc1c2cn3CCOc4cc(ccc4c3n2)c5cnn(c5)C(C)(C)C(=O)N
,PF-4989216,Pfizer,777877,,pI3K alpha,Investigational,DPT-110,Fc1cc(ccc1c2c(C#N)c(sc2c3nnc[nH]3)N4CCOCC4)C#N
,AZD-8186,AstraZeneca,777572,,pI3K beta,Investigational,DPT-110,C[C@@H](Nc1cc(F)cc(F)c1)c2cc(cc3C(=O)C=C(Oc23)N4CCOCC4)C(=O)N(C)C
,SAR-260301,Sanofi,780290,1260612-13-2,PI3K beta,Investigational,DPT-110,CC1Cc2ccccc2N1C(=O)CC3=NC(=CC(=O)N3)N4CCOCC4
,SGI-1776,Astex,757333,1173928-26-1,PIM-1,Investigational,DTP-110,CN1CCC(CNc2ccc3ncc(c4cccc(OC(F)(F)F)c4)n3n2)CC1
,AZD-1208,AstraZeneca,776066,,PIM-1,Investigational,DTP-110,N[C@@H]1CCCN(C1)c2c(\C=C\3/SC(=O)NC3=O)cccc2c4ccccc4
,H-89,Univ Penn,755766,127243-85-0,PKA,Investigational,DTP-110,Brc1ccc(\C=C\CNCCNS(=O)(=O)c2cccc3cnccc23)cc1
Chelerythrine ,MP-0922,Marinus,36405,3895-92-9,PKC,Investigational,DTP-110,COc1ccc2c(c[n+](C)c3c2ccc4cc5OCOc5cc34)c1OC
Staurosporine,AM-2282,Ajinomoto,755774,62996-74-1,PKC,Investigational,DTP-110,CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35
Sotrastaurin,AEB-071,Novartis,766819,425637-18-9,PKC,Investigational,DTP-110,CN1CCN(CC1)c2nc(C3=C(C(=O)NC3=O)c4c[nH]c5ccccc45)c6ccccc6n2
,PKM2 Activator 9,Agios,772991,1260074-86-9,PKM2,Investigational,DTP-110,COc1ccccc1N2CCN(CC2)C(=O)c3ccc(NS(=O)(=O)c4cccc5cccnc45)cc3
Rigosertib,ON-01910Na,Onconova,754344,592542-60-4,PLK-1,Investigational,DTP-110,COc1cc(OC)c(\C=C\S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1
,GSK-461364,GlaxoSmithKline,754354,929085-18-1,PLK-1,Investigational,DTP-110,C[C@@H](Oc1cc(sc1C(=O)N)n2cnc3ccc(CN4CCN(C)CC4)cc23)c5ccccc5C(F)(F)F
,BI-2536,Boehringer Ingelheim,755983,755038-02-9,PLK-1,Investigational,DTP-110,CC[C@H]1N(C2CCCC2)c3nc(Nc4ccc(cc4OC)C(=O)NC5CCN(C)CC5)ncc3N(C)C1=O
Volasertib,BI-6727,Boehringer Ingelheim,757149,755038-65-4,PLK-1,Investigational,DTP-110,CC[C@H]1N(C(C)C)c2nc(Nc3ccc(cc3OC)C(=O)N[C@@H]4CC[C@H](CC4)N5CCN(CC6CC6)CC5)ncc2N(C)C1=O
,TAK-960 analog,Takeda,761759,1157847-46-5,PLK-1,Investigational,DTP-110,COc1cc(ccc1Nc2ncc3N(C)C(=O)C(C)(C)CN(C4CCCC4)c3n2)C(=O)N[C@@H]5CCCN(C)C5
,Des-fluoro-TAK-960,Roche/Takeda,762154,1201692-18-3,PLK-1,Investigational,DTP-110,COc1cc(ccc1Nc2ncc3N(C)C(=O)C(F)(F)CN(C4CCCC4)c3n2)C(=O)NC5CCN(C)CC5
,TAK Plk inhibitor,Takeda,762418,1214266-16-6,PLK-1,Investigational,DTP-110,CC[C@H]1N(C2CCCC2)c3nc(Nc4ccc(cc4OC)C(=O)NC5CCN(CC5)C6CCN(CC7CC7)CC6)ncc3n8cnc(C#N)c18
,MLN-0905,Millenium,767470,1228960-69-7,PLK-1,Investigational,DTP-110,CN(C)CCCc1cnc(C)c(Nc2ncc3CC(=S)Nc4cc(ccc4c3n2)C(F)(F)F)c1
,TAK-960,Takeda,768072,1137868-52-0,PLK-1,Investigational,DTP-110,COc1cc(C(=O)NC2CCN(C)CC2)c(F)cc1Nc3ncc4N(C)C(=O)C(F)(F)CN(C5CCCC5)c4n3
,NMS-1286937 ,Nerviano,781344,1034616-18-6,PLK-1,Investigational,DTP-110,CN1CCN(CC1)c2ccc(OC(F)(F)F)c(Nc3ncc4CCc5c(nn(CCO)c5c4n3)C(=O)N)c2
Teniposide,VM-26,BMS,122819,29767-20-2,Podophyllotoxin,Approved,DTP-103,COc1cc(cc(OC)c1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](OC4OC5CO[C@H](OC5C(O)C4O)c6cccs6)c7cc8OCOc8cc27
,LGK-974,Novartis,777639,,Porcupine,Investigational,DTP-110,Cc1cc(ccn1)c2ncc(CC(=O)Nc3ccc(cn3)c4cnccn4)cc2C
Efatutazone,CS-7017,Daiichi,764579,223132-37-4,PPAR-gamma,Investigational,DTP-110,Cc1cc(Oc2ccc3nc(COc4ccc(CC5SC(=O)NC5=O)cc4)n(C)c3c2)cc(C)c1N
,FH-535,Fred Hutchinson,778746,108409-83-2,PPAR-gamma,Investigational,DPT-110,Cc1cc(ccc1NS(=O)(=O)c2cc(Cl)ccc2Cl)[N+](=O)[O-]
Megestrol acetate,PAR-100.2,BMS,71423,595-33-5,Progesteron Receptor,Approved,DTP-103,CC(=O)O[C@@]1(CC[C@H]2[C@@H]3C=C(C)C4=CC(=O)CC[C@]4(C)[C@H]3CC[C@]12C)C(=O)C
Bortezomib,PS-341; MLN-341,Millennium,756655,179324-69-7,Proteasome,Approved,DTP-103,CC(C)C[C@H](NC(=O)[C@H](Cc1ccccc1)NC(=O)c2cnccn2)B(O)O
Carfilzomib,ONO-7057,Onyx,758252,868540-17-4,Proteasome,Approved,DTP-103,CC(C)C[C@H](NC(=O)[C@H](CCc1ccccc1)NC(=O)CN2CCOCC2)C(=O)N[C@@H](Cc3ccccc3)C(=O)N[C@@H](CC(C)C)C(=O)[C@@]4(C)CO4
Ixazomib citrate,MLN-9708,Millenium,758254,12101902-80-8,Proteasome,Investigational,DTP-110,CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B2OC(=O)CC(CC(=O)O)(O2)C(=O)O
Ixazomib,MLN-2238,Millenium,766907,1072833-77-2,Proteasome,Investigational,DTP-110,CC(C)C[C@H](NC(=O)CNC(=O)c1cc(Cl)ccc1Cl)B(O)O
Delanzomib,CEP-18770,Cephalon,764334,847499-27-8,Proteosome,Investigational,DTP-110,
Oprozomib,ONX-0912  ,Onyx,766254,935888-69-0,Proteosome,Investigational,DTP-110,COC[C@H](NC(=O)[C@H](COC)NC(=O)c1cnc(C)s1)C(=O)N[C@@H](Cc2ccccc2)C(=O)[C@@]3(C)CO3
,MG-132,Millenium,782153,133407-82-6,Proteosome,Investigational,DPT-110,CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O
,PTC-691,PTC Therapeutics,782006,420126-30-3,PTC,Investigational,DTP-110,FC(F)(F)c1ccc(Nc2nc(cs2)c3c(nc4ccccn34)C(F)(F)F)cc1
Thioguanine,,GlaxoSmithKline,752,154-42-7,Purine Antagonist,Approved,DTP-103,NC1=NC(=S)c2[nH]cnc2N1
Mercaptopurine,6MP,GlaxoSmithKline,755,6112-76-1,Purine Antagonist,Approved,DTP-103,S=C1N=CNc2nc[nH]c12
Fludarabine,SHT-586,Bayer,312887,75607-67-9,Purine Antagonist,Approved,DTP-103,Nc1nc(F)nc2c1ncn2C3OC(COP(=O)(O)O)C(O)C3O
Fluorouracil,5-FU; Ro-29757,Roche,19893,51-21-8,Pyrimidine Antagonist,Approved,DTP-103,FC1=CNC(=O)NC1=O
Floxuridine,5-FdU,Roche,27640,50-91-9,Pyrimidine Antagonist,Approved,DTP-103,OCC1OC(CC1O)N2C=C(F)C(=O)NC2=O
Capecitabine,Ro-09-1978; RG-340; R-340,Chugai,712807,154361-50-9,Pyrimidine Antagonist,Approved,DTP-103,CCCCCOC(=O)NC1=NC(=O)N(C=C1F)C2OC(C)C(O)C2O
Amuvatinib,MP-470,SuperGen,754349,850879-09-3,RAD51,Investigational,DTP-110,S=C(NCc1ccc2OCOc2c1)N3CCN(CC3)c4ncnc5c4oc6ccccc56
,GW-5074,GlaxoSmithKline,755765,220904-83-6,Raf,Investigational,DTP-110,Oc1c(Br)cc(\C=C\2/C(=O)Nc3ccc(I)cc23)cc1Br
,ZM-336372,Astra Zeneca,756654,208260-29-1,Raf,Investigational,DTP-110,CN(C)c1cccc(c1)C(=O)Nc2ccc(C)c(NC(=O)c3ccc(O)cc3)c2
,MLN-2480,Millenium,766906,1096708-71-2,Raf,Investigational,DTP-110,C[C@@H](NC(=O)c1ncnc(N)c1Cl)c2ncc(s2)C(=O)Nc3cc(c(Cl)cn3)C(F)(F)F
Regorafenib,BAY-73-4506 ,Bayer,763932,755037-03-7,"Raf, MEK",Approved,DTP-103,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(c3)C(F)(F)F)c(F)c2)ccn1
Salirasib,KD-032,Concordia,755771,162520-00-5,Ras,Investigational,DTP-110,CC(=CCC\C(=C\CC\C(=C\CSc1ccccc1C(=O)O)\C)\C)C
Pluripotin,SC-1,Scripps,763525,839707-37-8,Ras; Gap,Investigational,DTP-110,CN1C(=O)N(Cc2cnc(Nc3cc(C)nn3C)nc12)c4cc(NC(=O)c5cccc(c5)C(F)(F)F)ccc4C
Tretinoin,Retenoic Acid,Janssen,122758,302-79-4,Retenoid,Approved,DTP-103,C\C(=C/C=C/C(=C/C(=O)O)/C)\C=C\C1=C(C)CCCC1(C)C
,Y-27632,Mitsubishi Tanabe Pharma,751297,146986-50-7,Rho,Investigational,DTP-110,C[C@@H](N)C1CCC(CC1)C(=O)Nc2ccncc2
,H-1152,,780205,,Rho,Investigational,DTP-110,C[C@H]1CNCCCN1S(=O)(=O)c2cccc3cncc(C)c23
,CX-5461,Cylene,782164,1138549-36-6,RNA polymerase,Investigational,DPT-110,CN1CCCN(CC1)c2ccc3C(=O)C(=C4Sc5ccccc5N4c3n2)C(=O)NCc6cnc(C)cn6
,SL-0101,Univ VA,703081,77307-50-7,RSK,Investigational,DTP-110,CC1OC(OC2=C(Oc3cc(O)cc(O)c3C2=O)c4ccc(O)cc4)C(O)C(OC(=O)C)C1OC(=O)C
,XL-541,Exelixis,768011,1221878-06-3,S1P1,Investigational,DTP-110,Fc1ccc(C[C@@H]2C[C@H](N(C2)C(=O)Cn3ccnn3)C(=O)Nc4ccc(Oc5ccc(F)cc5)cc4)cc1
Raloxifene,LY-156758,Eli Lilly,747974,82640-04-8,SERM,Approved,DTP-103,Oc1ccc(cc1)c2sc3cc(O)ccc3c2C(=O)c4ccc(OCCN5CCCCC5)cc4
,CB-64D,,754350,157752-20-0,Sigma agonist,Investigational,DTP-110,
Vismodegib,GDC-0449; RG-3616,Roche,755986,879085-55-9,SMO,Approved,DTP-103,CS(=O)(=O)c1ccc(C(=O)Nc2ccc(Cl)c(c2)c3ccccn3)c(Cl)c1
,HPI-1,UCSF,758486,599150-20-6,SMO,Investigational,DTP-110,
,LDE-225,Novartis,761385,956697-53-3,SMO,Investigational,DTP-110,C[C@@H]1CN(C[C@H](C)O1)c2ccc(NC(=O)c3cccc(c3C)c4ccc(OC(F)(F)F)cc4)cn2
Sonidegib,"LDE-225, diphosphonate salt",Novartis,761386,1218778-77-8,SMO,Investigational,DTP-110,C[C@@H]1CN(C[C@H](C)O1)c2ccc(NC(=O)c3cccc(c3C)c4ccc(OC(F)(F)F)cc4)cn2
,SEN-450,Siena Biotech,763758,1160830-00-1,SMO,Investigational,DTP-110,Clc1ccc(cc1c2nc3ccccc3[nH]2)N4CCC(CC4)N5CCCC5
Saridegib,IPI-926,Infinity,767123,1037210-93-7,SMO,Investigational,DTP-110,C[C@@H]1CN[C@@H]2[C@@H](C1)O[C@]3(CC[C@H]4[C@@H]5CC[C@@H]6CC(CC[C@]6(C)[C@H]5CC4=C(C)C3)NS(=O)(=O)C)[C@@H]2C
,LEQ-506,Novartis,767126,1057677-92-5,SMO,Investigational,DTP-110,CC(C)(O)c1ccc(nc1)N2CCN(CC2)c3nnc(Cc4ccccc4)c5ccccc35
,LY-2940680,Eli Lilly,767896,1258861-20-9,SMO,Investigational,DTP-110,CN(C1CCN(CC1)c2nnc(c3ccnn3C)c4ccccc24)C(=O)c5ccc(F)cc5C(F)(F)F
,TAK-441,Takeda,771858,1186231-83-3,SMO,Investigational,DTP-110,CCC1=Cc2c(C(=O)N1CC(=O)c3ccccc3)c(OCC(F)(F)F)c(C(=O)NC4CCN(CC4)C(=O)CO)n2C
,PF-04449913,Pfizer,775772,1095173-27-5,SMO,Investigational,DTP-110,CN1CC[C@H](C[C@@H]1c2nc3ccccc3[nH]2)NC(=O)Nc4ccc(cc4)C#N
,BMS-833923,,781469,1059734-66-5,SMO,Investigational,DPT-110,CNCc1ccc(C)c(NC(=O)c2ccc(Nc3nc(c4ccccc4)c5ccccc5n3)cc2)c1
,Bosutinib isomer,,755389,380843-75-4,Src,Investigational,DTP-110,COc1cc2c(Nc3cc(Cl)c(OC)c(Cl)c3)c(cnc2cc1OCCCN4CCN(C)CC4)C#N
,KX2-391,Kinex,756643,897016-82-9,Src,Investigational,DTP-110,O=C(Cc1ccc(cn1)c2ccc(OCCN3CCOCC3)cc2)NCc4ccccc4
Saracatinib,AZD-0530,AstraZeneca,758872,379231-04-6,Src,Investigational,DTP-110,CN1CCN(CCOc2cc(OC3CCOCC3)c4c(Nc5c(Cl)ccc6OCOc56)ncnc4c2)CC1
Bosutinib,SKI-506,Pfizer,765694,380843-75-4,Src; Bcr-abl; Stat5,Approved,DTP-103,COc1cc(Nc2c(cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)C#N)c(Cl)cc1Cl
,Cpd-401,Otsuka,757334,1150339-93-7,Stat 3,Investigational,DTP-110,CN(C(=O)c1ccc(cc1)C(F)(F)F)c2ccc(Oc3ccc4c(c3)cc(C(=O)N5CCN(Cc6ccc(OC(F)F)cc6)CC5)n4C)nc2
Golotimod,SCV-07,UC Berkeley,755401,229305-39-9,Stat-3,Investigational,DTP-110,
Sepantronium bromide,YM-155,Astellas,755387,781661-94-7,Survivan,Investigational,DTP-110,COCCn1c(C)[n+](Cc2cnccn2)c3C(=O)c4ccccc4C(=O)c13
,SR-13654,SRI,756662,666752-22-3,Survivan,Investigational,DTP-110,CCOC(=O)c1ccc2[nH]c(Cc3[nH]c4ccc(cc4c3C)C(=O)OCC)c(C)c2c1
,BAY 61-3606,Bayer,766992,732983-37-8,Syk,Investigational,DTP-110,COc1ccc(cc1OC)c2cc3nccn3c(Nc4ncccc4C(=O)N)n2
,R-406,Rigel,772498,841290-80-0,Syk,Investigational,DTP-110,COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)Nc4n3)n2)cc(OC)c1OC
Fostamatinib,R-788,Rigel,772992,914295-16-2,Syk,Investigational,DTP-110,COc1cc(Nc2ncc(F)c(Nc3ccc4OC(C)(C)C(=O)N(COP(=O)(O)O)c4n3)n2)cc(OC)c1OC
,P505-15,Biogen,776786,,Syk,Investigational,DTP-110,N[C@H]1CCCC[C@H]1Nc2ncc(C(=O)N)c(Nc3cccc(c3)n4nccn4)n2
,GS-9973,,781516,1229208-44-9,Syk,Investigational,DPT-110,C1CN(CCO1)c2ccc(Nc3nc(cn4ccnc34)c5ccc6cn[nH]c6c5)cc2
,SB-431542 ,GlaxoSmithKline,756649,301836-41-9,TGF-beta,Investigational,DTP-110,NC(=O)c1ccc(cc1)c2nc(c3ccc4OCOc4c3)c([nH]2)c5ccccn5
Galunisertib,LY-2157299,Eli Lilly,761216,700874-72-2,TGF-beta,Investigational,DTP-110,Cc1cccc(n1)c2nn3CCCc3c2c4ccnc5ccc(cc45)C(=O)N
,LY-2109761,Eli Lilly,765632,700874-71-1,TGF-beta,Investigational,DTP-110,C(CN1CCOCC1)Oc2ccc3c(ccnc3c2)c4c5CCCn5nc4c6ccccn6
Motexafin,PCI-0120,Pharmacyclics,761266,156436-89-4,Thioredoxin reductase,Investigational,DTP-110,CCc1c(CC)c2C=C3C(=C(C)C4=[N+]3[Gd+3]567([O-]C(=O)C)([O-]C(=O)C)[nH-]2c1C=C8C(=C(C)C(=[N+]58)C=[N+]6c9cc(OCCOCCOCCOC)c(OCCOCCOCCOC)cc9[N+]7=C4)CCCO)CCCO
,ONX-0801,Onyx,764764,501332-69-0,Thymidine Synthase,Investigational,DTP-110,OCC1=Nc2cc3CCC(N(CC#C)c4ccc(cc4)C(=O)N[C@@H](CCC(=O)N[C@H](CCC(=O)O)C(=O)O)C(=O)O)c3cc2C(=O)N1
Imiquimod,DZ-2636; R-837; S-26308; TMX-101,3M,369100,99011-02-6,TLR7,Approved,DTP-103,CC(C)Cn1cnc2c(N)nc3ccccc3c12
,VTX-2337,,777447,926927-61-9,TLR8,Investigational,DPT-110,CCCN(CCC)C(=O)C1=Cc2ccc(cc2N=C(N)C1)c3ccc(cc3)C(=O)N4CCCC4
Thalidomide,K-17,Celgene,66847,50-35-1,TNF-alpha,Approved,DTP-103,O=C1CCC(N2C(=O)c3ccccc3C2=O)C(=O)N1
Lenalidomide,CC-5013,Celgene,747972,191732-72-6,TNF-alpha,Approved,DTP-103,Nc1cccc2C(=O)N(Cc12)C3CCC(=O)NC3=O
Pomalidomide,CC-4047; CDC-394; IMID-4047,Celgene,775351,19171-19-8,TNF-alpha,Approved,DTP-103,Nc1cccc2C(=O)N(C3CCC(=O)NC3=O)C(=O)c12
,XAV-939 ,Novartis,755761,284028-89-3,TNKS,Investigational,DTP-110,Oc1nc(nc2CCSCc12)c3ccc(cc3)C(F)(F)F
Topotecan,S-104864-A,GlaxoSmithKline,609699,119413-54-6,Topo I,Approved,DTP-103,CC[C@@]1(O)C(=O)OCC2=C1C=C3N(Cc4cc5c(CN(C)C)c(O)ccc5nc34)C2=O
Irinotecan,CPT-11,Pfizer,616348,100286-90-6,Topo I,Approved,DTP-103,CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(OC(=O)N6CCC(CC6)N7CCCCC7)cc15)[C@@](O)(CC)C(=O)OC4
,7-Ethyl-10-hydroxycamptothecin,Yakult Honsha,673596,86639-52-3,Topo I,Investigational,DTP-110,CCc1c2CN3C(=O)C4=C(C=C3c2nc5ccc(O)cc15)[C@@](O)(CC)C(=O)OC4
,MLN-576,Xenova,754365,346689-77-8,Topo I,Investigational,DTP-110,COc1cccc2c1ccc3nc4cccc(C(=O)N[C@H](C)CN(C)C)c4nc23
,XR-5944,Xenova,754366,343247-32-5,Topo I,Investigational,DTP-110,Cc1cccc2nc3cccc(C(=O)NCCNCCNCCNC(=O)c4cccc5nc6cccc(C)c6nc45)c3nc12
,XR-5000,Xenova,754367,89459-25-6,Topo I,Investigational,DTP-110,CN(C)CCNC(=O)c1cccc2cc3ccccc3nc12
Etoposide,VP-16,Novartis,141540,33419-42-0,Topo II,Approved,DTP-103,COc1cc(cc(OC)c1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](OC4OC5COC(C)OC5C(O)C4O)c6cc7OCOc7cc26
Idarubicin,IMI-30,Pfizer,256439,58957-92-9,Topo II,Approved,DTP-103,CC1OC(CC(N)C1O)OC2CC(O)(Cc3c(O)c4C(=O)c5ccccc5C(=O)c4c(O)c23)C(=O)C
Epirubicin,IMI-28,Pfizer,256942,56420-45-2,Topo II,Approved,DTP-103,COc1cccc2C(=O)c3c(O)c4C[C@](O)(C[C@H](OC5CC(N)C(O)C(C)O5)c4c(O)c3C(=O)c12)C(=O)CO
Mitoxantrone,CL-232315,Amgen,279836,65271-80-9,Topo II,Approved,DTP-103,OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12
,XK-469,BMS,698215,157542-91-1,Topo II,Investigational,DTP-110,
Amonafide,CGX-571,Abbott,758251,69408-81-7,Topo II,Investigational,DTP-110,CN(C)CCN1C(=O)c2cccc3cc(N)cc(C1=O)c23
Vosaroxin ,SNS-595; SPC-595,Sunesis,760764,175414-77-4 ,Topo II,Investigational,DTP-110,CN[C@H]1CN(C[C@@H]1OC)c2ccc3C(=O)C(=CN(c4nccs4)c3n2)C(=O)O
,GENZ-644282,Sanofi,768112,529488-28-6,Topo-I,Investigational,DTP-110,CNCCN1C(=O)c2cc(OC)c(OC)cc2c3cnc4cc5OCOc5cc4c13
Vincristine,,,67574,2068-78-2,Tubulin,Approved,DTP-103,CC[C@]1(O)C[C@H]2CN(CCc3c([nH]c4ccccc34)[C@@](C2)(C(=O)OC)c5cc6c(cc5OC)N(C=O)[C@H]7[C@](O)([C@H](OC(=O)C)[C@]8(CC)C=CCN9CC[C@]67[C@H]89)C(=O)OC)C1
Vinorelbine,ANX-530; KW-2307; SDP-012,Novartis,608210,71486-22-1,Tubulin,Approved,DTP-103,
Docetaxel,ANX-514; RP-56976; SYP-0704A ,Sanofi,628503,114977-28-5,Tubulin,Approved,DTP-103,CC(=O)O[C@@]12CO[C@@H]1C[C@H](O)[C@]3(C)[C@@H]2[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](O)C3=O)C5(C)C)C
Lexibulin,CYT-997,YM Biosciences,758488,917111-44-5,Tubulin,Investigational,DTP-110,CCC[C@H](Nc1nc(ncc1C)c2ccc(NC(=O)NCC)c(OC)c2)c3cccnc3
Verubulin,EP-90745,Myrexis,758773,827031-83-4,Tubulin,Investigational,DTP-110,COc1ccc(cc1)N(C)c2nc(C)nc3ccccc23
Cabazitaxel,TAX-258; RPR-116258A; TXD-258; XRP-6258,Sanofi,761432,183133-96-2,Tubulin,Approved,DTP-103,CO[C@H]1C[C@H]2OC[C@@]2(OC(=O)C)[C@H]3[C@H](OC(=O)c4ccccc4)[C@]5(O)C[C@H](OC(=O)[C@H](O)[C@@H](NC(=O)OC(C)(C)C)c6ccccc6)C(=C([C@@H](OC)C(=O)[C@]13C)C5(C)C)C
,BAL-27862,Basilea,762598,798577-91-0,Tubulin,Investigational,DTP-110,Nc1ccc(cc1)C(=O)Cn2c(nc3ccccc23)c4nonc4NCCC#N
Ombrabulin,AC-7700,Sanofi,778448,181816-48-8,Tubulin,Investigational,DTP-110,COc1ccc(\C=C/c2cc(OC)c(OC)c(OC)c2)cc1NC(=O)[C@@H](N)CO
,Peptide [CRGDKGPDC - cys & cys bridge,,754347,,Tumor Penetrating Peptide,Investigational,DTP-110,NCCCCC1NC(=O)C(CC(=O)O)NC(=O)CNC(=O)C(CCCNC(=N)N)NC(=O)C(N)CSSCC(NC(=O)C(CC(=O)O)NC(=O)C2CCCN2C(=O)CNC1=O)C(=O)O
Cediranib,AZD-2171,AstraZeneca,755606,288383-20-0,VEGF,Investigational,DTP-110,COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN5CCCC5
 Pazopanib,GW-786034,GlaxoSmithKline,737754,635702-64-6,VEGFR,Approved,DTP-103,CN(c1ccc2c(C)n(C)nc2c1)c3ccnc(Nc4ccc(C)c(c4)S(=O)(=O)N)n3
Lenvatinib,E-7080,Eisai,755980,417716-92-8,VEGFR,Approved,DTP-103,COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(=O)N
,peptide R18 (14-3-3 antagonist),,756651,,VEGFR,Investigational,DTP-110,
Nintedanib,BIBF-1120,Boehringer Ingelheim,756659,656247-18-6,VEGFR,Investigational,DTP-110,COC(=O)c1ccc2\C(=C(\Nc3ccc(cc3)N(C)C(=O)CN4CCN(C)CC4)/c5ccccc5)\C(=O)Nc2c1
  Tivozanib,ASP-4130,Astellas,758007,475108-18-0,VEGFR,Investigational,DTP-110,COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC
Dovitinib,CHIR-258,Novartis,759661,405169-16-6,VEGFR,Investigational,DTP-110,CN1CCN(CC1)c2ccc3nc([nH]c3c2)C4=C(N)c5c(F)cccc5NC4=O
Motesanib,AMG-706,Amgen,760843,453562-69-1,VEGFR,Investigational,DTP-110,CC1(C)CNc2cc(NC(=O)c3cccnc3NCc4ccncc4)ccc12
,JI-101,Gilead,762381,900573-88-8,VEGFR,Investigational,DTP-110,COc1ccc(Br)cc1NC(=O)Nc2cccc3c2ccn3Cc4ccnc(N)c4
Orantinib,SU-6668,Pfizer,763929,252916-29-3,VEGFR,Investigational,DTP-110,Cc1[nH]c(\C=C\2/C(=O)Nc3ccccc23)c(C)c1CCC(=O)O
Brivanib,BMS-582664 ,BMS,764481,649735-63-7,VEGFR,Investigational,DTP-110,C[C@H](COc1cn2ncnc(Oc3ccc4[nH]c(C)cc4c3F)c2c1C)OC(=O)[C@H](C)N
Vatalanib,CGP-79787D,Novartis,772499,212142-18-2,VEGFR,Investigational,DTP-110,
Apatinib,YN-968D1,Jiangsu Hengrui ,772886,811803-05-1,VEGFR,Investigational,DTP-110,Cc1ccncc1Nc2ncccc2C(=O)Nc3ccc(cc3)C4(CCCC4)C#N
Rebastinib,DCC-2036,Deciphera,774831,1020172-07-9,VEGFR,Investigational,DTP-110,CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(nn3c4ccc5ncccc5c4)C(C)(C)C)c(F)c2)ccn1
,SG-00529,Paloma,775306,914913-88-5,VEGFR,Investigational,DTP-110,COc1ccc(COc2cc3OC(=O)c4cc(ccc4c3cc2OC)C(C)O)cc1
Telatinib,BAY-57-9352,Bayer,776017,332012-40-5,VEGFR,Investigational,DTP-110,CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c4ccoc24)ccn1
Lucitinib,E-3810,Advenchen,782762,1058137,VEGFR,Investigational,DTP-110,CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12
Vandetanib,ZD-6474,AstraZeneca,760766,443913-73-3,"VEGFR, PDGFR, EGFR",Approved,DTP-103,COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC4CCN(C)CC4
,MK-1775 ,Merck,754352,955365-80-7,Wee-1,Investigational,DTP-110,CN1CCN(CC1)c2ccc(Nc3ncc4C(=O)N(CC=C)N(c5cccc(n5)C(C)(C)O)c4n3)cc2
,IWR-1,UT Southwestern,756646,430429-02-0,Wnt,Investigational,DTP-110,O=C(Nc1cccc2cccnc12)c3ccc(cc3)N4C(=O)[C@@H]5[C@H]6C[C@H](C=C6)[C@@H]5C4=O
Allopurinol,BW-56-158,GlaxoSmithKline,1390,315-30-0,Xanthine Oxidase,Approved,DTP-103,O=C1NC=Nc2[nH]ncc12
,AEG-40730 ,Aegera,754359,934963-58-3,XIAP,Investigational,DTP-110,CN[C@@H](C)C(=O)N[C@@H]([C@@H](C)OCC#CC#CCO[C@@H](C)[C@H](NC(=O)C(C)NC)C(=O)N1CCC[C@@H]1CN(CCc2ccccc2)C(=O)C(F)(F)F)C(=O)N3CCC[C@H]3CN(CCc4ccccc4)C(=O)C(F)(F)F
